rfhg_204014.1

Basic information about the TSS

---

TSS ID: rfhg_204014.1 TSS ID(Version3): hg_172278.1 hg_172279.1 hg_172280.1 Species: human Chr: chr18		Start: 63367169 End: 63367247 Strand: -
Source datasets	FANTOM5|PRJNA4843412|DRA013844|PRJNA401781|PRJNA615891
Protocol	CAGE|NETCAGE|SLIC_CAGE|TIF-seq2
TSS cluster detected*	6

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000645214.2:0 ENST00000646205.1:0 ENST00000644624.1:0 ENST00000591902.6:0 ENST00000326575.9:0 ENST00000592327.1:0 ENST00000589530.5:0 ENST00000587292.1:0 X63657:0 AK025120:0 AK297670:0 AK312360:0 GeneID: 2531 HGNC/MGI_ID: HGNC:4021 UniProt_ID: A0A024R292 A0A2R8Y7U3 A0A2R8YF70 K7EQS7 K7ERC8 Q06136 Nearer transcript ids and distances: LP895373:-5 BC008797:-5 ENST00000585456.1:41 BT006782:51 KJ896837:51 AB529042:51 view more...

Gene_name: 3-ketodihydrosphingosine reductase Gene_symbol: KDSR Gene_synonyms: DHSR SDR35C1 Gene_source: HGNC:4021

TATA-Box annotation

---

Distance to TSS:	-2
Nearest PromoterID:	NM_002035
Entrez ID:	2531
Nearest Unigene:	Hs.74050
Nearest Refseq:	NM_002035
Nearest Ensembl:	ENSG00000119537
Gene Name:	3-ketodihydrosphingosine reductase
Gene Alias:	DHSR|EKVP4|FVT1|SDR35C1
Gene Type:	protein-coding
CpG%:	0.153846
GC%:	0.759494
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@KDSR p2@KDSR p3@KDSR p4@KDSR p5@KDSR p6@KDSR p7@KDSR p8@KDSR
Sample		p1@KDSR	p2@KDSR	p3@KDSR	p4@KDSR	p5@KDSR	p6@KDSR	p7@KDSR	p8@KDSR
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	12.66	18.70	5.65	0.00	1.36	0.00	0.58	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	17.20	18.82	4.86	0.20	0.81	0.20	0.20	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	13.70	21.80	7.14	0.19	0.96	0.19	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	12.47	15.80	7.48	0.00	1.04	0.42	0.00	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	18.67	18.67	7.65	0.00	0.90	0.90	0.00	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	13.37	17.06	7.17	0.00	1.55	0.39	0.39	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	23.53	17.65	11.33	0.00	0.87	0.44	0.22	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	20.10	11.14	7.99	0.00	1.21	0.24	0.48	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	20.09	16.67	8.12	0.21	0.85	0.43	0.21	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	22.03	22.61	7.54	0.00	1.16	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	18.59	16.98	5.26	0.00	0.40	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	14.23	20.73	3.25	0.00	2.03	0.41	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	14.83	12.41	7.25	1.61	0.64	0.32	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	12.78	10.37	5.26	0.90	0.90	0.30	0.30	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	12.51	12.29	5.05	1.10	0.22	0.22	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	15.09	13.58	3.52	0.50	0.50	0.00	0.25	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	16.82	13.32	6.12	0.66	0.44	0.22	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	14.76	11.81	6.75	0.00	0.84	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	19.19	17.06	6.93	0.00	0.00	1.07	0.00	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	16.10	14.89	4.36	0.15	0.45	0.00	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	15.50	11.09	5.21	0.13	0.00	0.27	0.27	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	14.67	13.46	6.04	0.69	0.35	0.17	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	15.77	12.80	5.43	0.39	0.39	0.26	0.00	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	12.86	11.89	5.10	0.73	0.24	0.00	0.00	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	18.83	14.71	4.13	0.52	0.52	0.26	0.52	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	17.41	16.46	4.75	0.32	1.27	0.00	0.32	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	17.58	9.89	4.40	0.00	1.10	0.00	0.00	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	15.09	14.62	3.77	0.24	0.47	0.47	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	15.67	14.86	3.72	0.32	0.48	0.00	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	13.93	14.48	4.89	0.72	0.90	0.18	0.18	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	16.96	7.96	4.19	0.21	0.42	0.00	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	14.85	12.31	2.93	0.59	0.39	0.78	0.39	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	15.83	7.60	4.64	0.42	0.42	0.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	16.82	10.56	7.09	0.33	0.33	0.00	0.16	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	16.08	12.34	4.49	0.75	0.75	1.12	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	19.93	11.88	6.13	0.57	0.96	0.00	0.57	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	12.06	11.24	4.70	0.61	0.00	0.00	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	15.92	10.28	4.84	0.40	0.60	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	13.51	11.07	3.78	0.81	0.81	0.27	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	13.20	11.04	6.24	0.24	0.24	0.24	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	14.35	9.65	4.71	0.00	0.24	0.00	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	14.20	12.44	3.22	0.15	0.44	0.44	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	10.12	10.54	3.80	0.63	0.84	0.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	12.76	13.11	4.02	0.35	0.35	0.35	0.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	11.44	11.44	3.81	0.20	0.40	0.40	0.40	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	12.56	10.00	6.51	0.23	0.47	0.23	0.00	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	11.52	12.24	3.36	0.48	0.96	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	10.13	11.03	5.07	0.60	0.30	0.30	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	13.88	11.97	3.59	0.24	0.48	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	10.72	10.31	4.65	1.21	0.20	0.40	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	14.35	12.91	3.69	0.20	0.41	0.00	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	14.23	12.90	4.00	0.22	1.11	0.00	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	69.96	13.99	13.99	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	12.77	8.87	2.48	0.00	0.35	0.00	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	6.30	11.93	2.98	0.00	0.33	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	9.23	6.71	8.39	0.84	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	7.35	11.94	2.76	0.00	0.00	0.00	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	11.34	15.56	2.92	0.32	0.65	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	9.96	11.88	2.25	0.64	0.32	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	11.63	10.06	4.09	0.31	0.63	0.00	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	11.28	15.51	2.12	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	9.53	14.58	4.49	0.56	0.56	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	12.74	11.15	3.18	0.00	0.00	0.80	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	10.87	11.89	5.10	0.34	1.02	0.00	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	9.10	11.37	4.87	0.00	0.65	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	9.94	9.58	2.13	0.35	0.35	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	16.16	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	63.18	0.00	15.79	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	11.70	11.21	5.36	0.00	0.49	0.00	0.49	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	6.45	8.93	3.47	0.99	0.50	0.00	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	9.38	10.79	5.16	0.00	0.47	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	7.95	16.23	3.64	0.00	0.00	0.00	0.66	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	12.06	14.54	3.40	0.00	0.31	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	8.87	11.62	6.11	0.61	1.22	0.00	0.00	0.31
Adipocyte - breast, donor1	11376-118A8	28.83	16.63	10.77	1.27	0.32	0.32	0.00	0.16
Adipocyte - breast, donor2	11327-117E4	19.73	17.97	5.45	0.80	0.64	0.00	0.48	0.48
Adipocyte - omental, donor1	11473-119C6	33.97	22.39	11.83	1.27	2.16	0.25	0.00	0.51
Adipocyte - omental, donor2	11474-119C7	20.93	12.71	2.99	0.00	0.75	0.00	0.75	0.75
Adipocyte - omental, donor3	11475-119C8	19.09	11.72	3.01	0.00	1.34	0.00	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	19.14	15.31	5.74	1.28	0.64	0.00	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	3.30	5.50	3.30	0.00	1.10	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	15.81	8.13	4.97	0.90	0.45	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	8.34	15.99	3.13	0.17	0.52	0.17	0.70	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	30.70	21.12	11.54	1.56	1.76	0.20	0.20	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	32.69	27.54	11.07	0.00	1.54	0.00	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	30.11	17.84	7.25	0.56	2.23	0.00	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	15.87	31.74	7.05	0.00	1.76	1.18	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	14.32	16.09	4.75	0.48	0.64	0.32	0.24	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	37.44	14.85	7.42	1.29	0.97	0.00	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	22.93	34.66	6.93	0.53	0.53	0.53	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	17.81	22.26	1.67	1.11	1.11	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	15.39	14.97	3.33	0.83	0.00	0.00	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	26.37	18.08	2.76	0.25	0.75	0.00	0.25	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	18.98	22.91	6.54	0.00	1.31	0.00	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	12.18	19.49	3.65	0.00	0.91	0.00	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	19.23	3.54	7.51	0.88	0.00	0.00	0.00	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	6.10	3.94	1.08	0.00	0.36	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	3.59	8.39	0.00	0.00	0.00	0.00	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	11.51	18.35	6.12	0.36	0.90	0.00	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	6.69	15.06	0.00	1.67	0.00	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	12.53	15.41	5.14	1.03	0.62	0.21	0.21	0.41
Anulus Pulposus Cell, donor1	11248-116E6	18.99	12.82	10.64	0.92	1.03	0.00	0.11	0.23
Anulus Pulposus Cell, donor2	11463-119B5	15.67	14.94	5.14	0.73	0.49	0.24	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	11.68	6.29	4.04	0.00	0.00	0.00	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	6.95	10.85	5.21	0.43	0.00	0.00	0.43	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	8.56	4.28	10.70	0.00	2.14	0.00	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	7.47	8.67	3.89	0.60	0.30	0.00	0.60	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	7.59	6.32	5.06	0.00	1.26	0.00	2.53	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	11.88	4.62	4.62	0.00	0.66	0.00	2.64	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	11.70	7.15	3.25	0.65	0.32	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	11.65	6.80	9.71	0.00	0.49	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	8.91	9.50	6.53	0.59	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	9.42	6.03	3.39	0.38	0.00	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	7.26	7.98	5.08	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	6.27	6.27	2.51	0.00	0.00	0.00	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	15.65	8.24	7.08	1.32	0.00	0.49	0.00	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	6.82	10.92	4.09	1.36	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	12.52	6.18	5.28	0.15	0.00	0.00	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	11.25	8.04	2.68	0.00	0.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	9.07	6.61	3.40	0.57	0.00	0.00	0.94	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	10.42	6.41	6.15	0.00	0.00	0.00	0.53	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	5.85	8.78	1.95	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	10.95	6.63	3.98	0.83	0.17	0.00	0.33	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	8.41	4.80	2.40	0.00	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	11.15	7.89	3.95	0.69	0.00	0.00	0.69	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	4.19	4.19	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	9.71	6.80	2.91	0.49	0.49	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	12.52	4.93	3.79	0.38	0.76	0.00	0.76	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	15.75	6.06	2.42	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	8.55	6.27	2.28	0.00	0.00	0.00	1.14	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	9.41	6.84	3.85	0.43	0.21	0.21	0.43	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	11.36	6.97	4.13	0.26	0.26	0.00	0.00	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	7.51	7.98	3.75	0.47	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	10.93	7.40	4.50	0.00	0.00	0.32	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	7.85	6.42	7.85	0.71	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	9.36	9.36	4.68	0.58	0.00	0.00	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	10.24	4.82	2.41	0.00	0.00	0.00	0.30	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	10.69	5.94	3.56	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	9.15	8.65	4.07	0.00	0.51	0.00	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	14.52	9.17	4.84	1.02	0.00	0.00	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	6.35	8.90	1.27	0.64	0.00	0.00	0.64	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	9.49	11.22	3.02	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	7.20	6.14	4.66	0.64	0.00	0.00	0.00	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	10.73	4.35	2.90	0.87	0.58	0.00	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	4.72	6.61	5.67	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	10.68	6.44	3.05	0.17	0.34	0.17	0.17	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	4.63	4.63	2.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	6.34	8.45	6.34	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	9.86	6.22	3.86	0.21	0.64	0.00	0.43	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	12.63	11.43	4.81	0.00	0.00	0.00	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	10.21	9.48	4.37	0.73	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	13.79	7.59	3.45	0.46	0.46	0.00	0.23	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	10.20	0.00	2.55	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	12.97	5.85	3.31	0.00	0.25	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	11.15	9.29	4.13	0.21	0.41	0.00	0.00	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	11.02	7.04	3.98	0.92	0.31	0.31	0.61	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	10.52	11.47	4.78	0.00	0.00	0.00	0.96	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	14.19	8.65	3.33	0.22	0.00	0.00	0.44	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	9.15	9.15	3.05	1.53	0.00	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	9.97	8.86	2.22	0.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	8.74	10.06	3.18	0.79	0.26	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	14.17	8.36	3.63	0.73	0.00	0.00	0.73	0.00
Astrocyte - cerebellum, donor1	11500-119F6	15.97	4.79	3.07	0.37	0.37	0.00	0.25	0.12
Astrocyte - cerebellum, donor2	11580-120F5	10.61	6.16	3.42	0.34	0.34	0.00	0.00	0.34
Astrocyte - cerebellum, donor3	11661-122F5	6.50	11.12	5.66	0.21	1.05	0.21	0.21	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	10.46	8.71	4.88	0.70	0.35	0.35	0.00	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	7.77	8.41	5.82	0.81	0.49	0.16	0.32	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	15.96	11.19	9.40	0.89	0.60	0.00	0.15	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	7.34	2.41	4.01	0.23	0.00	0.00	0.11	1.03
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	4.38	2.38	4.13	0.25	0.00	0.13	0.13	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	5.35	1.71	4.89	0.23	0.00	0.11	0.00	0.91
Basophils, donor1	12241-129G9	6.80	3.14	2.09	0.78	0.00	0.00	0.00	0.00
Basophils, donor2	12242-129H1	8.66	0.72	2.16	0.36	0.00	0.00	0.00	0.36
Basophils, donor3	12243-129H2	11.47	3.09	1.62	0.88	0.29	0.00	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	14.01	7.11	6.47	0.00	1.29	0.22	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	4.57	3.66	4.11	0.00	0.00	0.00	0.46	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	7.17	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	13.81	1.88	7.53	0.00	0.63	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	17.47	3.95	4.78	0.42	0.62	0.00	0.42	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	8.29	6.68	3.22	0.46	0.46	0.00	0.23	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	17.09	10.26	9.00	0.90	0.72	0.00	0.54	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	8.35	1.65	6.08	0.72	0.21	0.10	0.00	0.82
Burkitt's lymphoma cell line:RAJI	10476-106I8	13.28	0.93	11.88	1.86	0.23	0.00	0.23	2.10
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	18.23	20.47	6.72	0.96	0.64	0.00	0.00	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	5.64	2.82	1.69	0.56	0.56	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	13.92	6.31	2.41	0.19	0.19	0.00	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	13.17	5.49	2.20	0.44	0.22	0.22	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	41.89	21.79	5.66	2.55	1.42	0.00	0.00	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	40.56	19.71	5.69	3.03	1.90	0.00	0.00	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	45.69	23.01	3.94	1.64	0.99	0.33	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	19.66	8.96	4.19	0.43	0.00	0.00	0.29	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	20.22	12.07	2.11	0.60	0.00	0.30	0.30	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	16.82	14.45	4.03	0.47	0.71	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	13.06	8.70	2.18	0.00	0.17	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	11.87	6.07	1.66	0.00	0.28	0.00	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	15.12	11.40	1.74	0.50	0.50	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	20.17	9.79	5.29	0.59	0.20	0.20	0.78	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	21.01	7.30	3.74	1.07	0.00	0.18	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	28.73	12.40	4.57	0.87	0.44	0.00	0.22	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	11.94	9.13	2.11	0.47	0.47	0.00	0.00	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	7.92	6.34	2.64	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	16.64	4.44	4.44	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	14.58	8.78	4.16	0.45	0.15	0.00	0.15	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	16.16	5.79	1.20	1.00	0.40	0.00	0.00	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	17.91	7.70	2.91	0.83	0.42	0.00	0.21	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	11.67	8.47	2.97	0.23	0.23	0.00	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	12.67	6.11	2.71	0.00	0.45	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	6.98	8.29	2.18	0.44	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	35.51	14.53	7.26	0.81	0.00	0.00	1.08	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	40.82	13.43	9.94	1.22	0.70	0.00	0.35	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	44.19	13.05	10.94	1.68	0.00	0.00	0.42	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	11.94	7.16	1.84	0.37	0.37	0.00	0.00	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	9.16	7.40	2.11	0.70	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	10.09	8.77	0.44	0.00	0.44	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	17.79	6.80	4.01	0.35	0.35	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	20.07	6.32	4.09	0.37	0.74	0.00	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	26.73	12.07	6.68	0.86	0.43	0.22	0.43	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	6.14	7.78	1.23	0.82	2.05	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	8.11	6.26	3.01	0.00	0.46	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	10.67	7.66	2.78	0.00	0.46	0.00	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	12.86	3.05	2.83	0.44	0.00	0.00	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	11.55	2.77	2.54	0.92	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	9.31	1.52	3.47	0.43	0.43	0.00	0.22	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	13.39	5.45	5.45	0.93	0.00	0.00	0.00	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	16.77	4.02	4.19	0.35	0.35	0.00	0.00	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	11.15	2.01	2.23	0.89	0.00	0.22	0.00	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	8.42	2.55	2.55	0.77	0.51	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	8.34	3.29	3.07	0.00	0.44	0.00	0.22	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	8.00	1.47	3.37	0.21	0.21	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	8.13	0.00	6.10	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	9.49	0.00	4.07	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	10.36	0.00	9.32	1.04	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	15.46	2.13	6.40	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	13.94	0.54	3.75	0.00	0.00	0.00	0.00	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	11.93	0.70	6.32	1.40	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	7.84	0.00	5.49	0.78	0.78	0.00	0.00	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	17.14	1.32	5.27	1.32	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	17.26	2.47	7.40	1.64	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	12.33	0.73	7.25	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	14.14	2.52	1.51	0.00	0.00	0.00	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	3.23	0.40	2.02	0.40	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	1.20	2.00	1.60	0.40	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	15.06	7.03	6.02	0.00	0.00	0.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	37.08	7.30	9.55	0.00	0.56	0.00	0.00	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	13.15	10.15	6.39	0.38	0.75	0.38	0.00	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	11.73	16.69	12.63	0.45	1.13	0.23	0.00	0.23
CD4+ T Cells, donor1	11225-116C1	24.99	1.07	7.86	0.71	0.00	0.00	0.00	0.71
CD4+ T Cells, donor2	11306-117C1	23.88	3.06	7.35	1.22	0.00	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	30.50	2.13	8.84	0.30	0.30	0.00	1.22	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	33.69	0.00	9.19	0.00	0.00	0.00	0.00	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	32.34	0.00	10.11	1.12	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	19.26	0.00	9.49	0.86	0.00	0.00	0.86	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	33.19	0.95	8.06	0.47	0.00	0.00	0.00	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	27.39	0.00	12.64	1.40	0.00	0.00	0.00	2.81
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	9.89	0.00	13.18	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	24.28	0.29	10.55	1.16	0.00	0.00	0.29	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	29.83	0.17	10.85	1.69	0.00	0.00	0.68	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	19.67	0.32	7.74	0.64	0.00	0.00	0.00	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	31.38	0.00	13.90	0.45	0.00	0.00	0.45	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	46.82	0.35	12.23	0.70	0.00	0.00	0.35	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	17.16	0.00	9.68	1.32	0.44	0.00	0.00	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	14.76	0.84	5.90	1.26	0.00	0.00	0.00	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	15.58	1.25	5.19	1.04	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	11.36	0.33	5.01	0.67	0.00	0.00	0.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	28.55	0.54	9.52	0.54	0.00	0.00	0.27	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	30.55	1.61	9.11	0.54	0.00	0.00	1.07	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	25.11	0.00	5.38	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	33.01	0.74	10.57	1.48	0.00	0.00	0.19	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	36.82	0.22	10.83	1.08	0.00	0.00	0.22	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	21.44	0.21	7.15	1.47	0.21	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	38.93	2.53	8.60	1.01	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	35.09	0.87	10.83	0.87	0.43	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	17.00	0.44	7.41	0.00	0.00	0.00	0.44	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	17.82	1.48	13.36	0.99	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	22.16	0.92	12.00	0.92	0.00	0.00	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	19.54	0.00	13.96	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	35.72	3.60	8.58	0.83	0.28	0.00	0.28	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	30.92	1.47	7.85	0.98	0.00	0.00	0.49	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	26.18	0.00	12.32	1.54	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	21.13	1.79	9.67	0.36	0.00	0.36	0.00	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	20.77	1.38	8.31	1.38	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	18.33	1.96	3.93	0.33	0.33	0.00	0.00	0.33
CD8+ T Cells, donor2	11307-117C2	28.16	0.75	5.26	1.13	0.00	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	14.64	2.02	6.31	0.25	0.00	0.00	0.00	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	6.65	8.49	2.98	0.23	0.23	0.00	0.00	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	5.99	4.07	2.16	0.00	0.24	0.00	0.24	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	3.83	4.65	3.56	0.00	0.00	0.00	0.27	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	8.11	4.80	2.70	0.00	0.30	0.60	0.60	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	4.80	6.48	3.84	0.00	0.24	0.24	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	4.55	6.59	2.27	0.00	0.68	0.00	0.00	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	6.74	11.73	3.04	0.43	1.30	0.43	0.00	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	7.63	8.95	2.90	0.00	0.26	0.26	0.00	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	3.75	9.38	3.05	0.00	0.47	0.00	0.47	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	9.36	11.17	1.51	0.30	0.60	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	5.81	12.78	4.36	0.00	0.87	0.29	0.00	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	4.53	8.26	3.73	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	17.07	11.38	2.19	0.00	1.75	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	15.03	14.12	4.55	0.00	3.19	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	27.60	7.46	3.73	0.75	5.22	1.49	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	6.84	6.48	3.24	0.00	1.08	0.36	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	5.75	5.75	2.88	0.00	0.29	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	8.01	3.77	4.01	0.00	0.47	0.00	0.00	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	9.51	11.41	2.85	0.00	0.63	0.32	0.00	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	8.61	9.84	5.23	0.00	0.00	0.00	0.00	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	6.41	9.30	0.96	0.00	0.96	0.32	0.32	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	8.80	4.59	1.53	0.00	0.38	0.00	0.38	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	6.31	10.64	3.55	0.79	0.79	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	2.27	9.08	1.51	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	20.07	21.68	4.82	0.00	3.21	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	23.78	26.58	3.50	0.00	1.40	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	16.03	24.04	4.01	0.00	2.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	3.66	9.14	3.66	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	5.43	11.86	3.46	0.00	0.49	0.49	0.99	0.49
Cardiac Myocyte, donor3	11686-122I3	8.84	4.53	5.26	0.11	0.63	0.00	0.00	0.11
Chondrocyte - de diff, donor1	11261-116G1	13.87	5.20	3.12	0.35	1.04	0.00	0.00	0.35
Chondrocyte - de diff, donor2	11338-117F6	11.02	9.60	4.26	1.78	0.36	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	12.97	10.81	6.26	0.57	0.68	0.34	0.34	0.00
Chondrocyte - re diff, donor2	11339-117F7	42.97	20.59	8.95	0.90	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	29.93	27.50	9.71	1.21	0.40	1.21	0.40	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	14.57	15.38	8.61	1.49	0.46	0.57	0.11	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	10.90	13.47	6.41	0.86	0.43	0.21	0.64	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	12.39	13.01	6.19	0.88	0.53	0.18	0.53	0.44
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	19.07	23.75	5.87	1.28	0.83	0.18	0.18	0.83
Corneal Epithelial Cells, donor1	11526-119I5	10.76	7.25	6.37	0.22	0.88	0.00	0.00	0.88
Corneal Epithelial Cells, donor2	11606-120I4	12.51	12.51	6.83	0.00	0.00	1.14	0.00	1.14
Corneal Epithelial Cells, donor3	11687-122I4	17.13	10.74	11.76	1.02	1.79	0.00	0.26	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	10.57	8.42	2.64	0.33	0.00	0.00	0.17	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	11.35	6.62	2.84	0.63	0.32	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	10.35	6.90	17.25	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	8.53	6.16	1.51	0.22	0.54	0.00	0.00	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	12.30	4.44	3.42	0.00	0.00	0.00	0.00	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	15.02	6.53	3.92	1.96	0.65	0.00	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	15.49	4.36	1.94	0.97	0.48	0.00	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	8.84	2.17	5.84	0.33	0.00	0.00	0.00	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	7.04	3.52	3.52	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	10.75	3.11	3.11	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	11.01	4.72	3.93	0.79	0.39	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	11.93	5.53	5.53	0.58	0.29	0.29	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	11.06	7.53	4.47	0.71	0.47	0.00	0.00	0.00
Endothelial Cells - Artery, donor3	11413-118E9	8.06	2.80	4.21	0.18	0.00	0.35	0.18	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	17.29	3.99	6.43	0.44	0.00	0.00	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	31.34	4.26	9.74	0.91	0.00	0.00	0.00	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	20.58	4.23	4.79	0.56	0.56	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	7.13	4.46	0.89	0.30	0.00	0.00	0.30	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	6.25	4.17	1.04	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	5.96	4.11	2.55	0.00	0.14	0.00	0.00	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	13.20	4.40	2.80	0.80	0.00	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	9.96	4.19	2.62	0.00	0.00	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	17.89	7.45	7.33	1.24	0.62	0.00	0.00	0.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	10.21	5.87	6.52	0.87	0.00	0.00	0.00	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	10.38	5.01	5.50	0.37	0.24	0.24	0.12	0.49
Endothelial Cells - Vein, donor1	11267-116G7	11.38	3.41	2.28	1.14	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	8.38	3.49	2.10	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	8.48	5.18	4.24	0.16	0.47	0.00	0.00	0.47
Eosinophils, donor1	12244-129H3	30.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	16.50	0.00	1.65	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	3.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	13.68	6.60	6.11	0.24	0.00	0.00	0.24	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	20.80	2.08	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	16.27	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	13.14	13.96	4.93	1.23	0.00	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	11.93	4.27	5.47	0.55	0.55	0.22	0.66	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	7.15	6.18	0.54	0.22	0.11	0.00	0.11	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	14.92	8.25	6.67	0.61	0.24	0.00	0.00	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	17.06	7.51	6.69	1.09	0.82	0.14	0.00	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	17.40	8.33	5.06	0.74	0.53	0.21	0.42	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	15.81	22.13	15.28	0.00	0.53	0.26	0.00	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	13.95	13.62	4.65	0.33	0.66	0.66	0.66	0.00
Fibroblast - Cardiac, donor1	11268-116G8	8.62	9.07	4.08	0.00	0.00	0.45	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	9.85	9.10	3.79	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	13.72	6.31	6.47	0.32	0.32	0.00	0.16	0.32
Fibroblast - Cardiac, donor4	11452-119A3	12.43	10.31	7.88	1.21	0.61	0.30	0.00	0.91
Fibroblast - Cardiac, donor5	11456-119A7	19.16	7.36	6.22	0.51	0.00	0.13	0.38	0.25
Fibroblast - Cardiac, donor6	11460-119B2	16.83	5.46	4.24	0.61	0.30	0.15	0.76	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	15.81	13.40	4.15	0.54	0.40	0.40	0.00	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	16.39	20.71	2.59	1.29	0.43	0.43	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	16.11	2.93	7.32	0.00	0.00	0.00	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	12.92	18.22	10.15	0.23	0.46	0.23	0.00	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	31.72	18.15	11.53	2.37	0.68	0.00	0.17	0.85
Fibroblast - Dermal, donor1	11269-116G9	17.61	6.34	7.28	0.70	0.47	0.00	0.00	0.23
Fibroblast - Dermal, donor2	11346-117G5	10.85	5.66	2.36	0.00	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	21.03	8.22	11.61	0.97	0.60	0.12	0.36	0.60
Fibroblast - Dermal, donor4	11450-119A1	14.36	8.25	5.88	0.23	0.34	0.00	0.34	1.13
Fibroblast - Dermal, donor5	11454-119A5	17.79	8.72	7.85	0.00	0.17	0.35	0.35	0.52
Fibroblast - Dermal, donor6	11458-119A9	19.49	9.75	7.31	0.16	0.32	0.00	0.00	0.49
Fibroblast - Gingival, donor1	11237-116D4	28.94	9.79	12.29	0.62	0.62	0.00	0.42	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	9.96	15.72	6.29	0.52	0.52	0.00	0.00	0.26
Fibroblast - Gingival, donor2	11318-117D4	19.24	7.78	11.99	0.53	0.26	0.00	0.40	0.40
Fibroblast - Gingival, donor3	11394-118C8	29.78	20.98	12.28	0.68	0.87	0.10	0.39	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	18.70	15.58	10.39	2.08	0.00	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	20.97	17.80	5.64	1.41	0.35	0.18	0.18	0.88
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	14.50	11.22	4.99	0.94	0.31	0.00	0.16	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	12.04	11.09	4.87	0.81	0.68	0.27	0.27	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	7.41	30.70	4.23	0.71	1.06	0.35	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	11.26	13.16	4.83	0.58	0.29	0.00	0.15	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	11.18	13.77	4.50	0.55	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	15.58	15.03	6.36	0.66	0.22	0.00	0.11	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	11.74	26.27	5.14	1.47	0.44	0.15	0.15	0.44
Fibroblast - Lung, donor1	11270-116H1	21.75	8.16	12.23	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	43.27	22.38	8.95	0.00	2.98	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	28.70	19.42	16.67	1.27	0.00	0.42	0.63	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	21.66	9.16	7.50	0.00	0.83	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	16.78	11.19	0.00	0.00	0.00	0.00	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	7.84	8.96	3.08	0.56	0.28	0.28	0.28	0.28
Fibroblast - Mammary, donor1	11540-120B1	23.55	14.61	11.37	0.41	0.00	0.00	0.00	0.81
Fibroblast - Mammary, donor2	11620-122A9	19.97	7.99	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	11.91	5.96	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	19.79	5.82	11.44	0.97	0.39	0.19	0.19	0.78
Fibroblast - Periodontal Ligament, donor2	11319-117D5	13.04	9.10	12.13	0.91	0.46	0.30	0.15	1.52
Fibroblast - Periodontal Ligament, donor3	11395-118C9	37.33	10.10	14.99	0.92	0.00	0.31	0.00	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	11.83	12.98	4.20	0.00	0.38	0.00	0.38	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	16.74	11.07	6.21	0.54	0.27	0.54	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	17.28	21.34	9.86	0.81	0.58	0.93	0.23	0.58
Fibroblast - Pulmonary Artery, donor1	11250-116E8	14.48	5.53	9.06	0.77	0.44	0.00	0.22	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	17.07	8.53	6.50	1.63	0.41	0.20	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	13.36	6.68	6.01	0.67	0.67	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	14.23	9.49	5.93	0.40	0.00	0.00	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	10.32	24.61	5.56	0.99	0.20	0.00	0.00	0.60
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	8.53	10.48	2.66	0.36	0.00	0.18	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	13.60	4.93	3.94	0.20	0.20	0.00	0.00	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	12.34	16.55	6.62	0.60	0.60	0.00	0.30	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	12.63	10.15	3.67	0.65	0.43	0.00	0.00	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	4.30	15.44	3.04	0.25	0.51	0.00	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	16.74	10.83	2.46	0.82	0.49	0.16	0.00	0.66
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	13.63	15.24	16.04	0.20	0.80	0.40	0.00	0.80
Fibroblast - skin normal, donor2	11561-120D4	13.76	8.64	4.12	0.50	0.40	0.00	0.10	0.30
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	4.84	16.32	3.02	0.30	0.60	0.00	0.30	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	16.98	15.74	5.80	0.75	0.99	0.25	0.00	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	16.58	16.75	3.42	0.17	0.68	0.00	0.17	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	15.11	17.41	4.93	0.00	1.97	0.33	0.00	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	16.30	6.82	4.26	0.75	0.21	0.00	0.32	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	15.35	5.74	4.39	0.51	0.17	0.17	0.00	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	16.15	13.96	4.55	0.63	0.63	0.31	0.63	1.10
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	22.16	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	25.27	14.82	7.84	0.00	0.00	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	28.95	9.88	12.83	1.04	0.69	0.00	0.00	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	35.13	9.11	12.49	0.26	1.04	0.26	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	41.65	10.99	12.78	1.53	1.02	0.00	0.00	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	8.42	26.79	6.89	1.53	0.77	0.77	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	17.23	20.42	7.02	0.00	1.28	0.64	1.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	8.27	15.40	13.12	0.00	0.57	0.29	0.57	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	5.52	36.40	4.14	1.10	0.28	0.55	0.00	1.65
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	4.79	35.62	4.57	0.46	0.91	0.23	0.46	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	6.34	16.44	4.36	0.20	0.79	0.79	0.00	2.18
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	5.29	26.96	5.55	1.06	1.59	0.53	0.00	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	3.91	36.20	3.91	0.33	0.98	0.65	0.33	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	6.63	14.15	6.63	0.88	1.33	0.00	0.00	1.77
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	11.73	10.88	5.23	0.85	1.13	0.14	0.14	1.98
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	15.27	9.24	7.51	0.12	0.25	0.12	0.37	1.23
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	8.06	7.52	8.33	0.27	0.54	0.00	0.27	1.07
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	22.67	8.05	11.15	0.50	0.99	0.12	0.37	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	23.12	8.17	13.15	0.42	0.55	0.42	0.55	1.80
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	20.13	5.08	11.38	1.42	0.41	0.20	1.22	1.22
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	23.73	9.13	8.90	0.91	0.68	0.23	0.23	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	27.65	10.34	9.72	0.25	0.37	0.12	0.37	1.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	23.61	6.56	11.58	0.22	0.22	0.00	0.44	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	15.36	11.82	6.21	0.30	0.59	0.30	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	21.62	9.22	7.95	0.79	0.48	0.16	0.16	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	21.90	9.61	7.82	0.22	0.22	0.22	0.00	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	10.28	11.09	4.64	0.60	0.60	0.00	0.00	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	17.98	10.69	6.11	0.34	0.68	0.00	0.51	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	23.05	11.00	8.34	1.06	0.71	0.18	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	19.67	11.55	7.70	1.14	0.62	0.00	0.00	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	14.86	9.73	5.29	1.20	0.68	0.51	0.00	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	16.93	12.17	5.64	1.00	0.00	0.44	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	17.89	9.40	7.57	0.58	0.25	0.33	0.00	0.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	21.64	8.78	7.76	0.61	1.02	0.00	0.00	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	13.00	10.32	4.75	1.03	0.00	0.41	0.21	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	17.18	10.61	4.15	0.69	0.46	0.00	0.23	0.46
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	17.84	11.01	6.50	1.00	0.50	0.17	0.50	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	14.33	9.48	5.29	0.44	0.00	0.00	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	19.43	17.46	6.52	1.35	0.37	0.25	0.49	0.74
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	12.81	11.67	6.16	0.16	0.16	0.32	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	25.34	14.11	7.70	0.32	0.32	0.00	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	17.06	11.09	5.69	0.47	0.57	0.19	0.28	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	18.19	8.07	4.59	1.27	0.47	0.00	0.16	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	15.81	14.90	6.69	1.52	0.30	0.00	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	15.26	12.86	5.33	0.84	0.73	0.00	0.21	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	18.88	12.08	2.85	0.88	0.66	0.00	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	15.15	8.98	5.89	1.40	0.56	0.28	0.00	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	16.30	14.07	5.46	0.37	0.19	0.19	0.00	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	19.25	11.77	4.81	0.27	0.27	0.27	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	18.67	13.62	7.65	1.07	0.15	0.15	0.15	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	20.86	10.49	5.05	0.65	0.13	0.13	0.26	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	24.40	10.84	7.32	0.81	1.08	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	16.04	12.54	4.24	0.74	0.74	0.00	0.37	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	14.69	11.84	4.82	1.32	0.44	0.44	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	25.79	11.90	4.96	0.00	2.98	1.98	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	12.00	13.59	4.09	0.53	1.06	0.00	0.13	1.06
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	14.32	12.91	3.83	0.61	0.61	0.20	0.40	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	43.97	31.26	8.90	3.56	1.52	0.00	0.25	0.76
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	6.57	5.97	4.18	0.00	0.40	0.20	0.20	1.19
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	12.33	8.17	7.86	0.31	0.46	0.15	0.15	2.47
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	9.00	12.27	8.80	0.41	0.82	0.20	0.20	3.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	6.26	11.27	4.69	0.31	0.63	0.00	0.31	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	5.65	6.78	5.09	0.28	0.28	0.00	0.00	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	9.69	9.22	7.38	0.92	0.92	0.00	0.46	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	0.00	22.27	7.42	2.47	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	8.51	9.67	7.74	0.77	0.39	1.16	0.00	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	9.63	8.02	3.21	1.60	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	8.69	24.34	1.74	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	7.49	9.76	6.18	0.65	1.30	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	5.35	9.06	2.88	0.00	0.82	0.00	1.24	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	3.33	16.66	0.00	3.33	3.33	0.00	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	5.87	11.19	5.03	1.40	0.56	0.00	0.00	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	7.52	10.13	6.86	0.98	1.63	0.00	0.00	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	9.23	13.42	3.36	0.00	0.00	0.00	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	5.09	7.32	4.77	0.32	0.32	0.00	1.27	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	4.42	9.17	3.40	0.68	0.34	0.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	6.26	8.35	2.09	2.09	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	8.59	9.16	5.73	0.57	0.57	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	5.62	6.81	5.92	0.89	0.59	0.30	0.30	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	10.16	15.25	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	4.14	19.47	5.38	0.83	0.83	0.83	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	4.14	15.42	3.45	0.46	0.00	0.00	0.00	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	0.00	10.54	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	5.00	12.30	1.92	0.38	0.38	0.38	0.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	3.59	10.76	1.63	0.33	0.33	0.00	0.33	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	4.01	10.70	2.68	0.00	0.00	0.67	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	7.71	12.33	5.01	0.39	0.39	0.00	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	5.48	35.60	3.42	0.34	2.40	0.00	0.34	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	9.94	12.42	4.97	0.00	2.48	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	7.08	7.55	4.72	1.42	0.94	0.00	0.00	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	5.43	7.24	4.83	0.00	0.60	0.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	4.58	18.31	5.60	0.00	0.51	0.00	0.00	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	6.78	11.57	4.79	0.40	0.40	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	7.89	17.27	2.47	0.00	0.00	0.99	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	9.44	12.98	5.90	0.00	0.00	1.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	7.58	11.67	2.33	1.17	0.00	0.58	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	8.78	10.53	3.95	0.88	0.00	0.44	0.88	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	7.63	13.56	0.85	0.00	1.70	0.00	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	3.58	14.33	2.39	0.60	0.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	3.40	15.53	2.91	0.00	0.00	0.49	1.46	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	14.84	11.41	3.42	1.14	1.14	0.00	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	9.56	13.31	5.41	0.00	0.42	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	7.87	4.50	7.87	0.00	2.25	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	19.66	13.64	8.25	0.63	0.63	0.00	0.95	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	17.96	7.52	9.19	0.42	1.25	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	16.25	6.85	8.12	0.58	0.23	0.35	0.46	0.70
Hep-2 cells mock treated, biol_rep2	11899-125E9	15.53	8.10	11.48	0.84	0.34	0.00	0.34	0.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	15.47	6.37	9.78	0.68	0.23	0.00	0.68	0.91
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	20.33	8.74	11.59	1.09	0.22	0.00	0.77	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	17.62	7.09	12.89	1.29	0.43	0.00	1.07	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	15.93	6.24	7.10	0.22	0.00	0.00	0.43	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	18.43	8.84	9.71	2.24	0.25	0.00	0.37	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	20.07	8.06	10.81	1.03	0.17	0.00	0.17	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	16.02	6.41	5.77	0.96	0.32	0.00	0.64	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	12.31	4.48	3.36	0.56	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	7.36	4.76	4.33	0.43	0.43	0.00	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	13.22	5.29	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	8.47	5.64	2.47	0.35	0.00	0.35	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	6.54	7.27	1.45	0.00	0.00	0.00	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	11.89	5.94	5.42	0.35	0.17	0.17	0.70	0.35
Hepatocyte, donor1	11523-119I2	49.63	44.79	15.74	2.42	1.21	0.00	0.00	1.21
Hepatocyte, donor2	11603-120I1	127.13	29.09	28.01	1.08	1.08	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	45.40	22.09	9.20	0.61	0.61	0.00	0.00	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	22.19	6.53	12.40	0.65	1.31	0.00	0.65	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	7.52	10.84	4.02	0.00	0.17	0.00	0.00	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	13.45	5.90	8.37	0.41	0.27	0.14	0.00	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	6.37	6.37	3.18	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	6.68	6.68	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	27.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	6.92	4.15	2.77	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	7.51	5.01	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	11.87	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	5.13	10.25	2.56	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	9.14	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	1.62	4.87	1.62	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	1.67	1.67	1.67	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	10.89	3.63	0.00	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	0.00	9.26	5.29	0.00	1.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	1.11	3.33	3.33	0.00	0.00	0.00	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	5.24	5.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	3.15	3.78	0.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	4.64	4.64	1.55	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	14.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	1.94	5.81	3.88	0.00	0.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	1.61	14.49	3.22	0.00	3.22	0.00	0.00	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	5.70	10.59	0.81	0.81	0.81	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	3.36	4.20	5.46	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	14.37	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	4.02	7.23	3.21	0.00	0.80	0.00	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	2.77	3.69	0.92	0.92	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	30.16	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	4.25	4.25	4.25	0.47	0.00	0.00	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	0.91	3.63	1.81	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	1.08	10.76	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	0.00	8.89	6.35	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	16.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	1.28	8.93	0.64	0.00	0.00	0.00	0.00	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	1.82	9.11	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	5.00	9.28	3.57	0.00	0.00	0.00	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	3.32	3.32	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	20.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	1.23	2.78	1.54	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	3.51	10.54	5.27	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	3.14	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	4.87	4.87	3.48	0.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	6.64	8.85	2.21	2.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	0.00	12.97	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	2.62	3.49	1.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	4.50	4.50	0.00	2.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	3.48	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	3.20	1.07	2.13	0.00	1.07	0.00	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	2.77	0.00	5.54	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	5.70	2.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	0.00	2.76	5.52	0.00	0.00	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	6.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	6.21	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	4.23	4.23	0.00	0.00	0.00	0.00	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	41.86	9.87	17.22	1.06	1.63	0.00	0.08	0.00
Keratinocyte - epidermal, donor2	11349-117G8	14.64	5.27	4.10	0.00	0.00	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	28.87	5.68	14.39	0.66	0.66	0.09	0.38	0.47
Keratinocyte - oral, donor1	11251-116E9	37.46	16.91	23.38	0.79	1.48	0.23	0.34	0.68
Keratocytes, donor1	11527-119I6	26.13	18.22	12.38	1.03	1.03	0.34	0.00	0.00
Keratocytes, donor2	11607-120I5	9.37	0.00	4.69	1.17	1.17	0.00	1.17	1.17
Keratocytes, donor3	11688-122I5	30.63	16.40	9.29	1.19	0.59	0.00	0.00	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	10.99	35.17	6.59	0.00	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	7.55	6.47	3.24	0.00	0.00	0.00	1.08	1.08
Lens Epithelial Cells, donor2	11609-120I7	16.03	7.15	5.42	0.46	0.46	0.00	0.00	0.46
Lens Epithelial Cells, donor3	11690-122I7	12.01	7.16	3.73	0.30	0.61	0.20	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	15.30	2.25	7.35	0.83	0.12	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	11.72	4.19	5.30	0.56	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	15.43	6.61	7.24	0.31	0.16	0.00	0.47	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	9.14	2.69	2.69	0.00	0.00	0.00	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	14.81	4.10	3.47	0.32	0.00	0.63	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	10.35	4.64	3.77	0.75	0.11	0.00	0.22	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	11.90	3.69	5.34	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	11.12	3.03	4.30	0.51	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	9.71	4.22	3.52	0.84	0.14	0.00	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	14.63	2.77	7.52	0.40	0.00	0.40	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	12.41	4.07	6.01	0.39	0.19	0.00	0.39	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	6.48	3.89	3.89	0.19	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	11.85	3.48	4.18	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	15.74	3.58	4.77	0.24	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	9.61	3.57	3.30	0.14	0.00	0.00	0.14	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	11.09	4.00	5.24	1.54	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	11.53	3.74	5.30	0.00	0.00	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	9.88	6.04	4.76	0.55	0.18	0.00	0.37	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	9.54	3.95	5.27	0.33	0.33	0.66	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	12.01	4.10	3.81	0.00	0.29	0.00	0.00	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	6.47	4.98	1.99	0.25	0.00	0.25	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	8.73	1.94	5.33	0.48	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	14.81	2.69	5.92	0.81	0.27	0.00	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	9.69	5.60	4.39	0.45	0.15	0.30	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	16.59	1.56	4.67	0.52	0.00	0.00	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	17.38	2.72	6.91	0.21	0.42	0.00	0.42	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	9.47	4.51	2.26	0.30	0.15	0.30	0.45	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	10.32	2.06	8.25	0.00	0.69	0.00	0.69	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	15.62	3.39	5.27	0.19	0.00	0.19	0.00	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	7.63	3.39	3.92	0.32	0.21	0.00	0.42	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	15.02	3.39	6.78	0.48	0.00	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	15.55	4.30	5.95	0.33	0.00	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	10.04	3.47	4.21	0.50	0.00	0.00	0.12	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	14.07	1.48	3.33	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	16.80	2.72	5.44	0.25	0.25	0.00	0.74	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	8.11	2.75	3.30	0.69	0.14	0.14	0.14	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	11.58	2.25	6.43	1.29	0.32	0.00	0.64	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	18.87	4.87	6.39	0.00	0.30	0.00	0.00	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	11.62	6.30	5.04	0.70	0.14	0.14	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	9.60	2.13	4.98	0.71	0.00	0.36	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	11.15	3.39	5.82	0.48	0.00	0.00	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	7.62	3.89	3.27	0.47	0.00	0.00	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	12.53	2.86	3.94	0.00	0.00	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	15.68	3.27	6.53	0.33	0.33	0.00	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	8.00	4.00	1.65	0.00	0.00	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	17.82	2.72	7.80	0.74	0.12	0.00	0.12	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	12.55	2.56	4.87	0.26	0.00	0.00	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	8.95	5.07	4.18	0.30	0.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	15.86	6.80	0.00	0.00	0.00	0.00	0.00	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	8.44	10.74	0.77	0.00	0.00	0.00	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	1.48	9.65	4.45	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	5.92	17.35	2.12	0.42	0.42	0.00	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	4.92	16.88	1.41	0.00	0.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	7.47	6.54	0.93	1.87	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	4.12	5.15	1.03	0.52	1.55	0.00	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	0.00	10.71	1.19	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	4.07	8.82	1.36	0.00	0.68	0.45	0.00	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	5.23	9.60	3.49	0.29	0.29	0.00	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	3.15	8.10	0.45	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	5.69	8.81	1.49	0.14	0.41	0.27	0.00	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	1.54	9.24	2.57	0.51	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	5.29	7.76	1.76	0.00	0.71	0.00	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	3.33	10.66	0.67	1.33	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	5.09	18.85	3.57	0.00	2.04	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	7.47	11.74	1.87	0.53	0.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	3.97	8.69	1.32	0.38	1.32	0.38	0.00	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	4.91	11.66	2.45	0.00	0.00	0.61	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	5.71	5.71	1.63	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	5.00	11.04	1.87	0.42	0.21	0.21	0.00	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	5.04	8.41	1.96	0.28	0.56	0.00	0.28	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	7.21	5.15	1.03	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	4.64	12.19	1.74	0.29	0.58	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	5.98	9.86	2.69	0.30	0.00	0.00	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	6.09	13.28	0.00	0.00	0.55	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	6.72	11.31	1.77	0.35	1.41	0.00	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	7.38	11.06	1.11	0.00	0.37	0.00	0.74	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	4.61	5.76	1.15	0.00	1.15	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	6.14	9.59	0.38	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	7.93	9.06	0.57	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	5.74	5.74	0.00	0.00	0.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	3.62	7.68	2.26	0.00	0.45	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	5.75	8.62	1.44	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	5.23	7.47	1.49	0.00	0.75	0.75	1.49	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	5.95	10.40	3.34	0.37	1.49	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	6.46	9.91	2.58	0.00	0.86	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	5.14	6.85	0.00	0.00	0.00	0.00	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	5.33	8.00	2.67	0.00	1.00	0.00	0.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	8.45	6.64	1.21	0.60	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	6.40	6.40	2.13	0.00	1.42	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	3.09	6.87	0.69	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	3.22	9.66	1.07	0.54	0.54	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	3.37	5.39	1.35	0.00	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	4.82	7.78	2.59	0.37	0.37	0.37	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	6.98	8.14	1.16	0.00	0.00	0.00	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	2.12	8.46	2.12	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	4.40	5.60	2.00	0.00	0.40	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	5.81	18.17	1.45	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	6.13	19.93	2.30	0.00	3.83	0.00	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	3.45	14.31	0.99	0.99	0.99	0.00	0.49	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	6.59	14.11	0.94	0.00	0.00	0.00	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	5.03	13.58	1.51	0.00	0.50	0.00	0.00	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	5.86	11.72	0.90	0.00	0.00	0.00	0.00	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	3.44	20.65	0.00	0.00	1.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	5.34	9.35	1.78	0.00	0.89	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	5.47	17.21	0.39	0.00	0.39	0.00	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	3.30	15.83	0.00	0.00	0.00	0.00	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	4.67	10.38	0.52	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	4.38	11.38	2.19	0.00	1.31	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	5.03	13.98	1.12	0.00	0.00	0.00	0.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	6.62	14.13	2.65	0.00	0.88	0.00	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	5.79	9.64	0.00	0.39	0.00	0.39	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	5.06	11.65	2.03	0.00	1.52	0.00	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	0.96	12.98	3.84	0.48	0.96	0.00	0.00	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	6.36	11.13	1.99	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	4.25	14.58	1.22	0.00	0.61	0.61	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	4.15	12.45	0.00	0.00	2.08	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	3.42	11.02	1.90	0.38	0.38	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	7.75	10.84	0.52	0.00	1.03	0.00	0.00	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	4.84	11.49	0.60	0.00	0.60	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	5.70	9.19	3.80	0.00	0.63	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	5.33	10.66	1.60	0.00	0.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	4.02	12.64	1.15	0.00	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	8.74	10.28	1.03	0.51	0.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	8.49	12.03	2.12	0.71	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	6.24	15.32	1.70	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	3.74	12.48	1.66	0.42	1.25	0.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	3.13	11.75	0.00	0.00	0.78	0.78	1.57	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	5.85	7.52	1.67	0.00	0.84	0.00	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	6.50	12.55	1.39	0.00	0.46	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	2.01	6.02	2.68	0.67	0.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	6.95	9.09	1.07	0.00	0.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	2.83	9.70	2.42	0.81	2.02	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	6.42	5.51	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	5.33	2.67	0.89	0.89	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	6.27	9.12	0.57	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	3.83	6.14	1.53	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	5.47	3.28	2.19	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	4.90	5.35	0.45	0.45	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	5.46	5.98	2.08	0.00	0.26	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	4.64	5.30	0.66	0.66	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	6.24	4.16	2.08	0.00	0.00	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	34.42	7.75	5.01	3.42	0.23	0.00	0.46	0.23
Macrophage - monocyte derived, donor2	11313-117C8	15.41	3.30	3.12	1.47	0.55	0.18	0.00	0.18
Macrophage - monocyte derived, donor3	11389-118C3	20.45	8.65	5.77	1.84	0.66	0.39	0.00	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	30.80	4.78	10.62	1.59	0.00	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	51.34	11.41	11.57	0.79	0.32	0.16	0.16	0.16
Mallassez-derived cells, donor3	11930-125I4	36.55	8.20	9.31	0.42	0.28	0.28	0.42	0.00
Mammary Epithelial Cell, donor1	11273-116H4	49.02	20.93	17.74	1.30	1.89	0.10	0.10	0.80
Mammary Epithelial Cell, donor2	11350-117G9	41.98	13.32	10.42	0.58	0.87	0.00	0.29	0.58
Mammary Epithelial Cell, donor3	11422-118F9	23.45	9.73	10.97	0.25	0.50	0.00	0.25	0.75
Mast cell - stimulated, donor1	11487-119E2	13.56	2.71	2.71	0.00	0.00	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	14.06	6.60	4.11	0.54	0.22	0.11	0.00	0.32
Mast cell, donor2	11565-120D8	21.69	23.77	5.05	0.59	2.08	0.00	0.00	2.08
Mast cell, donor3	11566-120D9	22.51	26.34	5.85	0.68	1.58	0.00	0.00	1.58
Mast cell, donor4	11567-120E1	23.76	24.47	5.50	0.89	1.77	0.18	0.00	1.24
Mast cell, expanded and stimulated, donor5	11940-126A5	10.65	6.88	4.21	0.22	0.22	0.11	0.22	0.44
Mast cell, expanded and stimulated, donor8	11942-126A7	10.51	4.67	2.92	0.58	0.58	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	14.23	6.08	3.79	1.15	0.00	0.00	0.11	0.46
Mast cell, expanded, donor8	11941-126A6	20.42	8.03	7.03	1.17	0.17	0.00	0.33	0.50
Melanocyte - dark, donor1	11502-119F8	16.62	5.67	6.87	0.40	0.00	0.00	0.00	0.70
Melanocyte - dark, donor2	11582-120F7	6.23	9.69	4.15	0.00	0.35	0.35	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	53.75	13.76	9.56	2.90	0.58	0.07	0.14	0.65
Melanocyte - light, donor1	11274-116H5	23.74	13.16	4.94	0.71	0.47	0.00	0.24	0.00
Melanocyte - light, donor2	11351-117H1	32.08	8.19	4.09	0.68	0.00	0.00	1.36	0.00
Melanocyte - light, donor3	11423-118G1	11.27	5.20	3.47	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	45.50	11.04	14.27	2.19	0.62	0.21	0.52	0.52
Melanocyte, donor2 (MC+2)	12739-135I3	57.28	11.83	15.60	1.34	0.54	0.00	0.00	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	36.96	17.41	6.43	1.61	1.07	0.80	0.80	0.00
Meningeal Cells, donor1	11493-119E8	33.74	7.44	9.68	0.37	0.37	0.12	0.12	0.62
Meningeal Cells, donor2	11573-120E7	23.33	11.00	7.48	0.44	0.44	0.00	0.00	0.88
Meningeal Cells, donor3	11654-122E7	30.81	10.43	12.47	1.22	0.33	0.24	0.24	0.65
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	7.70	7.98	6.84	0.57	0.57	0.00	0.29	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	38.44	7.85	8.35	1.81	0.70	0.00	0.10	0.40
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	3.94	7.88	2.63	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	3.92	3.92	9.16	2.62	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	12.92	8.61	7.89	0.00	0.00	0.00	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	26.68	7.84	6.78	1.06	0.21	0.00	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	14.07	6.03	2.51	0.50	0.50	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	8.13	4.61	2.64	0.00	0.00	0.00	0.00	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	12.42	4.38	2.92	0.73	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	7.98	5.93	4.91	0.61	0.41	0.20	0.20	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	20.08	8.31	4.29	0.14	0.28	0.14	0.42	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	9.29	7.81	2.23	0.00	1.12	0.00	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	28.16	16.45	8.42	1.18	0.53	0.00	0.26	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	3.56	8.31	1.19	0.00	0.30	0.00	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4.67	4.67	2.34	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	5.12	5.76	5.76	0.00	1.28	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	25.52	8.86	13.47	0.71	0.71	0.35	0.00	1.42
Mesenchymal stem cells - hepatic, donor0	11218-116B3	23.14	13.45	6.88	0.63	0.31	0.00	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	10.16	5.08	6.53	0.00	0.00	0.73	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	19.89	7.96	4.77	0.00	1.59	0.27	0.00	0.53
Mesothelial Cells, donor2	12156-128G5	13.51	7.01	5.51	0.50	1.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	9.83	6.21	4.77	0.43	0.51	0.14	0.07	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	20.25	14.85	2.70	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	23.40	9.60	2.46	1.72	0.25	0.00	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	14.43	5.59	4.12	0.59	0.00	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	20.74	13.83	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	22.01	6.51	2.79	0.31	0.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	11.62	2.28	1.66	0.83	0.00	0.00	0.00	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	13.90	2.32	2.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	18.27	8.51	2.25	1.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	15.36	3.26	3.72	2.33	0.93	0.00	0.00	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	14.23	9.14	2.85	0.81	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	14.25	3.96	2.77	1.19	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	8.55	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	15.04	7.96	4.42	1.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	14.06	3.42	4.18	0.38	0.00	0.00	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	11.84	9.21	0.00	2.63	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	17.19	7.00	2.55	0.21	0.21	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	9.21	3.68	1.84	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	16.99	8.05	1.49	0.30	0.89	0.30	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	11.74	1.68	1.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	67.90	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	12.04	6.02	2.26	0.75	0.00	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	9.27	2.85	3.33	0.00	0.24	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	10.50	7.74	3.87	0.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	17.50	5.99	2.07	0.00	0.23	0.23	0.00	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	11.57	5.05	2.52	0.21	0.21	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	7.13	7.54	2.24	0.20	0.20	0.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	16.30	6.01	2.36	1.72	0.00	0.00	0.43	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	14.23	3.56	3.11	0.44	0.00	0.00	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	10.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	13.14	7.45	3.07	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	12.17	6.08	1.52	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	19.88	8.28	1.66	0.00	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	13.86	7.61	3.26	0.82	0.27	0.00	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	12.06	5.29	1.47	1.18	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	7.63	5.45	1.09	1.09	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	17.30	3.84	2.40	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	14.41	4.00	2.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	12.34	12.34	4.11	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	21.02	7.01	4.00	1.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	53.89	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	12.23	12.23	2.04	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	19.27	6.13	2.63	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	15.45	3.31	2.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	7.68	3.84	3.20	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	14.63	5.45	3.47	0.74	0.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	9.05	4.18	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	13.26	15.47	4.42	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	24.27	4.44	4.44	1.03	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	9.19	2.19	3.06	0.44	0.88	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	12.07	12.43	2.84	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	13.19	6.17	3.93	1.12	0.28	0.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	11.22	3.33	1.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	9.91	8.16	4.66	0.00	0.00	1.75	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	15.38	6.64	3.32	0.90	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	11.69	4.17	1.67	0.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	7.22	7.22	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	12.01	6.46	5.54	0.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	12.52	3.98	1.14	1.71	0.57	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	12.99	12.71	3.32	0.41	0.14	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	19.95	7.26	4.41	0.52	0.00	0.26	0.26	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	13.30	3.00	2.14	0.00	0.43	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	7.62	13.34	3.81	0.64	1.27	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	13.34	9.61	3.47	1.07	0.27	0.00	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	15.86	5.99	2.10	0.30	0.30	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	9.18	10.03	3.25	0.57	0.00	0.14	0.00	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	18.16	6.69	6.05	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	13.93	4.86	4.20	0.66	0.00	0.00	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	9.10	12.51	3.03	0.38	0.76	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	15.06	7.95	3.13	1.14	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	9.34	4.92	2.70	0.25	0.25	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	9.78	7.17	3.91	0.00	0.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	14.70	11.17	4.70	0.59	0.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	13.26	6.05	2.88	0.29	0.29	0.29	0.29	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	11.95	9.48	2.06	0.41	0.00	0.82	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	12.80	6.85	3.87	0.60	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	30.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	32.08	8.91	7.13	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	30.56	12.16	6.24	1.31	0.33	0.00	0.99	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	14.73	7.36	2.10	0.00	1.05	0.00	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	35.19	8.90	2.77	2.17	0.20	0.00	0.40	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	25.15	22.35	4.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	20.65	9.76	4.88	2.63	0.75	0.00	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	17.84	7.46	3.20	1.86	0.00	0.00	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	31.22	5.99	3.73	1.36	0.23	0.00	0.23	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	25.79	8.84	0.74	1.47	0.00	0.00	0.00	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	26.38	10.63	3.30	2.20	0.00	0.00	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	18.67	9.33	3.11	1.56	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	45.43	8.55	3.74	3.74	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	19.32	3.86	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	20.20	9.09	1.01	2.02	0.00	0.00	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	18.55	5.90	4.64	0.84	0.00	0.00	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	50.39	10.90	2.72	2.72	2.72	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	16.53	6.36	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	19.44	6.48	0.81	1.62	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	25.68	13.59	3.02	3.02	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	79.94	57.10	0.00	0.00	28.55	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	35.89	68.51	6.52	0.00	42.41	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	23.76	28.51	0.00	0.00	33.27	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	150.59	0.00	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	20.90	7.76	7.54	0.86	0.22	0.00	0.43	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	17.25	13.07	7.32	1.05	1.57	0.00	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	15.35	15.35	4.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	19.20	12.52	8.35	0.42	1.25	0.00	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	11.03	21.87	6.27	0.57	0.38	0.00	0.38	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	9.58	14.36	6.38	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	17.00	8.16	8.84	0.00	0.00	0.00	0.00	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	42.27	7.35	11.03	1.84	0.00	0.00	1.84	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	20.93	14.23	7.95	0.42	0.00	0.00	0.42	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	16.27	8.60	6.51	0.23	0.23	0.00	0.46	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	13.51	13.78	5.40	0.54	0.00	0.27	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	13.24	17.24	6.52	1.05	1.05	0.42	0.00	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	66.81	11.13	33.40	11.13	0.00	0.00	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	13.40	10.42	7.45	0.00	0.50	0.50	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	12.18	15.43	8.12	0.27	0.54	0.81	0.00	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	22.44	9.97	5.21	0.00	1.36	0.45	0.00	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	16.49	14.53	7.02	0.16	0.98	0.00	0.16	0.65
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	20.96	12.58	5.47	0.36	0.73	0.00	0.91	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	22.81	12.73	5.83	0.00	1.59	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	22.81	12.01	7.20	1.20	0.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	17.39	37.41	4.59	0.66	0.33	0.98	0.66	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	23.58	12.52	7.48	0.65	0.00	0.00	0.16	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	19.93	21.87	4.59	0.88	0.71	0.00	0.53	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	15.47	7.03	5.63	1.41	0.70	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	28.50	10.11	8.73	0.46	0.92	0.00	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	19.28	18.00	6.75	1.29	0.00	0.32	0.32	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	22.42	23.11	7.59	1.38	0.69	0.34	1.03	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	32.87	10.11	2.53	0.00	0.00	0.00	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	23.17	18.71	7.35	1.11	1.34	0.00	0.00	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	18.21	20.32	7.62	0.42	0.00	0.42	0.85	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	17.33	25.87	7.60	0.71	0.95	0.00	0.00	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	18.46	18.03	9.44	0.86	0.00	0.00	0.00	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	0.00	9.03	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	13.66	19.99	5.00	0.67	1.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	10.82	15.33	1.80	0.00	0.90	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	14.68	13.49	5.56	1.19	0.00	0.00	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	25.07	14.86	7.43	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	18.54	16.27	2.65	0.38	0.00	0.00	0.00	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	16.29	9.78	2.61	0.65	1.63	0.33	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	22.66	20.48	3.92	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	10.40	14.93	4.52	0.45	0.00	0.00	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	11.46	14.99	3.53	0.88	0.88	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	31.91	12.63	4.65	0.00	1.33	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	18.35	17.86	3.97	0.99	0.50	0.00	0.50	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	11.10	14.93	3.06	0.00	0.38	0.00	0.38	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	25.71	22.99	12.40	0.60	1.21	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	12.82	12.82	4.20	0.66	0.66	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	19.65	9.49	7.45	0.00	0.00	0.00	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	40.88	25.55	10.22	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	23.78	20.73	3.05	1.83	0.00	0.61	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	11.33	15.74	2.52	0.31	0.63	0.00	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	25.12	26.94	9.08	0.30	1.51	0.30	0.00	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	10.28	15.82	5.54	0.00	0.79	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	15.87	32.88	7.94	0.00	1.13	1.13	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	65.75	10.12	0.00	5.06	0.00	0.00	10.12	0.00
Myoblast, donor1	11241-116D8	24.47	6.46	9.94	1.12	0.87	0.25	0.12	0.25
Myoblast, donor2	11322-117D8	14.77	8.82	14.00	1.15	0.77	0.00	0.96	0.58
Myoblast, donor3	11398-118D3	22.20	6.89	8.41	0.67	0.17	0.34	0.00	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	71.07	0.44	23.79	3.06	0.00	0.00	0.00	0.15
Natural Killer Cells, donor1	11230-116C6	13.84	0.92	5.54	0.31	0.31	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	22.92	1.81	3.92	0.30	0.30	0.00	0.30	0.30
Natural Killer Cells, donor3	11387-118C1	11.23	1.66	2.39	0.37	0.00	0.00	0.00	0.00
Neural stem cells, donor1	11275-116H6	14.15	33.75	8.71	0.36	1.45	0.00	0.00	0.36
Neural stem cells, donor2	11352-117H2	9.63	25.03	3.85	0.00	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	14.79	4.55	5.69	0.00	1.14	0.00	0.00	0.00
Neurons, donor2	11574-120E8	8.37	7.27	6.60	0.66	0.66	0.00	0.00	0.66
Neurons, donor3	11655-122E8	9.04	7.40	4.93	1.64	0.00	0.00	0.00	0.00
Neutrophils, donor1	11233-116C9	1.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	2.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	6.11	1.22	2.44	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	22.20	17.22	9.38	0.95	1.07	0.24	0.47	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	11.72	9.44	5.54	0.33	0.33	0.00	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	20.86	6.42	4.01	0.60	0.60	0.00	0.00	0.40
Olfactory epithelial cells, donor1	11933-125I7	15.14	10.74	4.68	0.55	0.41	0.28	0.00	0.14
Olfactory epithelial cells, donor2	11934-125I8	14.19	14.62	4.63	0.29	0.43	0.29	0.87	0.29
Olfactory epithelial cells, donor3	11935-125I9	13.51	13.85	4.88	0.23	1.02	0.23	0.23	0.23
Olfactory epithelial cells, donor4	11936-126A1	13.05	22.89	8.47	0.68	1.17	0.29	0.00	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	17.45	10.83	6.02	0.60	0.00	0.00	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	16.38	8.08	3.62	1.28	0.43	0.00	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	21.72	9.14	4.57	0.00	2.29	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	27.31	9.93	4.97	1.24	0.62	0.00	0.00	1.24
Osteoblast, donor1	11277-116H8	6.45	6.06	3.32	0.20	0.39	0.39	0.00	0.20
Osteoblast, donor2	11354-117H4	11.94	9.13	6.32	1.40	1.40	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	10.49	8.18	3.91	0.36	0.00	0.00	0.18	0.36
Pancreatic stromal cells, donor1	11249-116E7	23.33	13.06	8.17	1.18	0.42	0.08	0.67	0.67
Pericytes, donor1	11491-119E6	10.13	7.45	3.56	0.11	0.11	0.00	0.00	0.11
Pericytes, donor2	11571-120E5	5.43	12.90	3.17	0.23	0.91	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	12.82	6.51	5.90	0.41	0.41	0.00	0.41	0.20
Perineurial Cells, donor1	11499-119F5	16.28	8.59	8.59	0.90	0.34	0.00	0.11	1.13
Perineurial Cells, donor2	11579-120F4	10.95	8.74	5.52	0.46	0.46	0.09	0.00	0.64
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	15.94	2.23	6.37	0.64	0.00	0.00	0.00	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	8.57	4.65	3.18	0.73	0.24	0.00	0.24	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	16.95	3.11	5.44	0.26	0.00	0.00	0.00	0.26
Placental Epithelial Cells, donor1	11278-116H9	14.11	27.74	5.50	0.24	0.96	0.00	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	7.76	7.76	3.33	0.00	1.11	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	5.50	16.69	3.14	0.20	0.59	0.20	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	12.03	11.08	8.23	0.63	0.95	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	21.95	16.51	8.25	1.88	1.31	0.19	0.00	0.94
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	10.44	9.01	5.35	0.39	0.65	0.00	0.00	0.52
Preadipocyte - breast, donor2	11328-117E5	19.14	9.68	6.30	1.35	0.00	0.00	0.23	0.00
Preadipocyte - omental, donor1	11468-119C1	40.49	16.84	13.00	1.92	0.75	0.43	0.11	0.00
Preadipocyte - omental, donor2	11329-117E6	28.81	9.60	6.55	1.75	0.87	0.44	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	23.64	13.18	11.89	0.86	0.86	0.00	0.29	0.72
Preadipocyte - perirenal, donor1	11469-119C2	9.84	9.84	5.91	0.00	0.00	0.00	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	11.36	6.76	6.76	0.61	0.31	0.31	0.00	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	14.52	9.03	6.73	0.71	0.53	0.00	1.06	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	11.07	12.43	5.45	0.34	0.51	0.17	0.17	0.17
Preadipocyte - visceral, donor1	11280-116I2	18.91	10.34	10.43	1.12	0.84	0.09	0.00	0.19
Preadipocyte - visceral, donor2	11357-117H7	21.17	18.41	9.66	1.38	0.00	0.00	0.92	0.00
Preadipocyte - visceral, donor3	11429-118G7	15.88	6.69	5.43	0.21	0.42	0.00	0.10	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	5.13	11.16	2.41	0.30	0.00	0.00	0.15	0.00
Prostate Epithelial Cells, donor2	11331-117E8	32.09	11.65	11.78	0.95	0.27	0.00	0.81	0.00
Prostate Epithelial Cells, donor3	11404-118D9	24.49	9.37	10.23	0.67	0.37	0.12	0.24	0.49
Prostate Stromal Cells, donor1	11254-116F3	19.48	7.52	7.97	1.14	0.46	0.11	0.00	0.34
Prostate Stromal Cells, donor2	11332-117E9	22.41	10.76	6.99	0.54	0.36	0.18	0.36	0.00
Prostate Stromal Cells, donor3	11405-118E1	21.90	9.18	5.11	1.04	0.21	0.31	0.10	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	18.61	5.84	7.66	0.73	0.73	0.00	0.00	1.46
Renal Cortical Epithelial Cells, donor2	11596-120H3	21.69	7.21	10.67	0.83	0.35	0.28	0.07	0.35
Renal Epithelial Cells, donor1	11517-119H5	10.65	5.58	4.57	1.01	0.00	0.00	0.00	0.51
Renal Epithelial Cells, donor2	11597-120H4	12.80	5.69	9.25	1.42	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	18.95	9.42	11.33	0.74	0.53	0.32	0.11	0.64
Renal Glomerular Endothelial Cells, donor1	11514-119H2	10.21	3.40	4.09	0.00	0.68	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	16.04	3.37	4.99	0.40	0.00	0.13	0.13	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	10.66	7.99	7.99	0.44	0.00	0.00	0.00	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	7.32	5.32	3.99	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	8.58	7.04	3.08	0.22	0.66	0.00	0.00	0.44
Renal Mesangial Cells, donor2	11598-120H5	11.91	6.27	5.64	1.25	0.00	0.00	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	3.88	5.27	2.77	0.00	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	22.28	3.49	9.13	1.34	1.34	0.00	0.27	0.81
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	14.34	8.01	2.11	0.42	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	10.03	7.33	9.26	0.96	0.39	0.39	0.00	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	15.56	7.78	7.00	0.26	0.52	0.52	0.00	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	13.64	6.82	4.55	0.57	0.57	0.00	0.00	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	8.23	4.12	8.23	1.03	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	19.82	11.54	7.78	1.00	0.75	0.00	0.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	24.19	42.50	8.15	0.67	2.41	0.00	0.40	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	10.72	10.72	3.57	0.00	0.89	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	8.26	9.91	1.65	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	12.18	19.14	3.48	1.16	0.58	0.00	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	5.20	3.77	1.30	0.26	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	4.37	5.36	2.28	0.20	0.00	0.20	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	6.25	3.23	2.34	0.33	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	5.95	5.09	1.86	0.25	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	5.36	3.50	2.21	0.70	0.58	0.23	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	5.08	5.32	2.08	0.23	0.46	0.00	0.46	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	4.11	4.79	1.51	0.41	0.27	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	4.08	6.20	3.48	0.30	0.15	0.00	0.00	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	6.99	4.84	3.05	0.00	0.36	0.00	0.00	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	4.16	6.46	1.43	0.29	0.43	0.00	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	3.22	6.33	2.58	0.11	0.21	0.00	0.21	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	5.09	5.09	1.11	0.66	0.22	0.00	0.22	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	4.59	6.88	1.15	0.38	0.19	0.00	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	3.73	6.52	1.58	0.28	0.09	0.00	0.09	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	7.70	7.33	3.19	0.19	1.13	0.19	0.19	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	4.64	7.96	1.59	0.13	0.13	0.00	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	4.77	7.98	2.14	0.19	0.58	0.00	0.00	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	4.20	5.92	3.44	0.19	0.57	0.57	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	4.16	7.05	1.28	0.11	0.00	0.00	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	4.48	7.57	1.68	0.56	0.28	0.56	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	5.13	6.84	1.54	0.00	0.34	0.17	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	5.11	7.48	1.46	0.00	0.18	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	4.05	7.85	1.35	0.25	0.25	0.12	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	5.10	9.00	2.82	0.40	0.27	0.27	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	4.01	7.78	0.47	0.24	0.71	0.00	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	3.57	8.13	1.59	0.20	0.20	0.00	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	4.21	13.10	3.27	0.00	0.23	0.00	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	4.35	7.05	1.45	0.00	0.41	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	4.65	5.31	1.33	0.00	0.22	0.22	0.88	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	5.22	5.43	2.51	0.21	0.84	0.00	0.00	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	3.10	6.46	1.75	0.27	0.00	0.00	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	5.45	8.00	1.02	0.34	0.51	0.17	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	4.43	9.25	1.93	0.58	0.00	0.00	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	2.92	5.85	1.55	0.17	0.00	0.34	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	4.94	8.92	1.10	0.27	0.14	0.14	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	4.43	6.90	1.31	0.16	0.16	0.00	0.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	3.58	4.77	0.68	0.17	0.34	0.34	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	3.85	5.03	1.63	0.44	0.30	0.00	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	4.26	7.20	1.60	0.27	0.00	0.00	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	8.99	9.82	2.49	0.55	0.41	0.00	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	6.90	4.52	4.29	0.48	0.24	0.00	0.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	7.46	9.47	3.83	0.81	0.20	0.00	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	5.93	7.53	1.70	0.09	0.19	0.00	0.09	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	8.04	10.13	2.79	1.75	0.35	0.00	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	9.07	18.13	2.12	0.30	0.60	0.00	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	6.24	7.83	1.47	0.12	0.24	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	16.01	19.50	5.09	0.87	0.58	0.29	0.00	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	10.34	7.91	4.87	1.83	0.61	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	4.52	6.33	0.90	0.00	0.60	0.30	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	10.86	14.48	5.88	0.45	0.90	0.00	0.23	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	12.28	17.07	5.69	0.30	0.00	0.00	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	9.92	12.16	2.83	0.35	0.71	0.12	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	10.46	16.65	5.34	1.28	0.85	0.43	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	8.41	12.62	6.01	0.60	0.00	0.60	0.00	0.00
Schwann Cells, donor1	11498-119F4	12.41	6.58	4.14	0.00	0.19	0.00	0.19	0.00
Schwann Cells, donor2	11578-120F3	3.40	3.40	10.21	3.40	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	7.45	10.08	5.70	0.88	0.66	0.00	0.44	0.00
Sebocyte, donor1	11220-116B5	26.84	12.60	18.62	0.55	1.10	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	17.00	9.65	10.11	0.46	0.92	0.00	0.92	0.46
Sebocyte, donor3	11378-118B1	22.05	9.69	11.13	0.62	0.21	0.21	0.00	0.41
Sertoli Cells, donor1	11255-116F4	21.54	18.22	8.28	0.00	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	19.77	5.65	5.65	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	8.89	10.56	4.31	0.26	0.44	0.18	0.18	0.70
Skeletal Muscle Cells, donor2	11358-117H8	13.73	11.57	1.45	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	10.87	10.87	1.67	0.00	0.84	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	11.00	8.95	6.44	0.16	0.63	0.00	0.47	0.16
Skeletal Muscle Cells, donor5	11455-119A6	10.41	8.47	4.61	0.45	0.45	0.00	0.15	0.15
Skeletal Muscle Cells, donor6	11459-119B1	17.24	6.93	6.93	0.62	0.62	0.31	0.31	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	15.50	13.48	7.18	0.38	1.89	0.00	0.25	1.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	10.27	11.84	6.56	1.00	0.57	0.00	0.57	0.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	12.10	6.35	9.72	0.60	0.10	0.10	0.10	0.60
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	6.15	10.70	3.29	0.51	0.25	0.17	0.00	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	7.24	2.90	7.96	1.45	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	3.03	4.68	1.79	0.41	0.28	0.00	0.28	0.41
Skin - palm, donor1	10286-104F7	48.35	37.61	13.43	2.69	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	16.87	9.66	7.64	0.29	0.72	0.00	0.29	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	27.81	34.35	7.36	1.64	1.64	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	12.85	13.24	7.27	0.39	0.52	0.13	0.26	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	23.77	6.81	10.15	0.42	0.83	0.00	0.00	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	14.35	13.22	6.61	0.42	0.70	0.00	0.84	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	29.81	26.22	16.70	0.21	2.33	0.42	0.00	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	15.44	18.36	6.22	0.75	0.67	0.22	0.37	0.60
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	15.43	2.16	1.23	0.00	0.00	0.31	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	34.24	10.89	8.67	0.22	0.44	0.00	0.00	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	15.87	5.29	2.94	1.76	0.59	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	11.05	6.63	5.97	0.22	0.88	0.00	0.00	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	10.24	3.54	3.94	0.39	0.39	0.00	0.00	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	24.72	4.64	6.95	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	12.01	10.01	6.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	13.17	5.59	6.39	0.00	0.13	0.00	0.00	0.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	9.75	13.52	4.65	0.44	0.22	0.44	0.66	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	15.62	6.27	3.84	0.64	0.38	0.00	0.00	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	16.61	6.84	5.21	2.28	1.30	0.00	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	16.24	8.86	5.32	2.07	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	16.94	6.12	6.26	0.57	0.14	0.28	0.28	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	12.69	4.39	6.83	0.16	0.33	0.16	0.00	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	23.75	18.27	8.83	1.22	0.30	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	12.63	6.82	3.28	0.00	0.76	0.25	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	0.00	6.12	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	8.58	4.29	2.86	0.48	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	13.57	9.00	6.19	0.88	0.15	0.15	0.00	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	13.13	6.67	4.52	1.29	0.00	0.22	0.65	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	13.75	6.61	5.35	0.63	0.21	0.00	0.00	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	11.76	4.18	4.64	0.77	0.15	0.00	0.00	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	10.78	3.23	1.08	0.00	1.08	0.00	1.08	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	15.84	4.48	4.78	0.00	0.60	0.00	0.30	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	6.83	6.83	4.10	0.00	0.00	0.34	0.68	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	16.65	9.97	6.60	0.86	0.55	0.00	0.08	0.79
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	20.93	13.18	9.86	1.71	1.21	0.00	0.10	0.40
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	19.11	14.34	9.78	0.68	1.59	0.23	0.68	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	9.66	5.43	1.21	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	22.52	7.42	10.07	1.06	0.53	0.00	0.00	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	13.05	8.52	5.73	0.27	0.27	0.13	0.13	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	11.65	10.89	4.76	1.00	0.25	0.25	0.25	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	32.22	11.41	6.09	1.01	0.76	0.25	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	12.51	8.44	6.48	1.06	0.30	0.00	0.30	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	12.75	6.75	5.25	0.75	0.75	0.75	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	7.75	7.75	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	10.70	7.91	5.58	0.00	0.00	0.00	0.00	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	15.15	13.13	6.06	0.00	1.01	0.00	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	13.48	10.66	2.82	0.63	0.00	0.00	0.31	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	7.96	3.24	4.42	0.59	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	12.66	5.75	7.58	0.83	0.58	0.00	0.00	0.50
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	21.96	14.01	7.94	0.00	0.00	0.93	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	10.07	4.03	3.89	0.14	0.58	0.00	0.00	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	5.35	5.10	4.59	0.76	0.51	0.00	0.00	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	8.84	4.14	1.88	0.19	0.38	0.00	0.19	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	12.72	7.13	5.45	0.56	0.42	0.00	0.00	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	11.14	6.62	3.52	0.42	0.50	0.08	0.00	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	24.29	9.52	7.14	0.95	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	7.10	2.69	3.18	0.49	0.24	0.00	0.00	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	15.47	7.51	4.42	0.88	0.88	0.22	0.22	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	15.51	3.80	3.51	0.88	0.59	0.00	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	24.49	28.38	6.03	0.39	1.17	0.39	0.39	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	23.01	13.75	9.26	1.06	0.00	0.26	0.53	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	21.57	11.53	5.21	0.00	1.12	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	20.48	11.50	5.03	1.08	0.72	0.00	0.36	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	31.23	9.94	10.79	1.70	0.85	0.00	0.28	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	13.79	9.85	6.70	0.00	0.79	0.39	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	18.03	14.73	6.35	0.76	0.51	0.25	0.25	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	22.36	19.17	5.19	0.40	0.00	0.00	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	34.69	21.32	7.52	0.42	0.84	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	32.09	17.42	7.33	0.46	0.92	0.00	0.00	0.46
Synoviocyte, donor1	11291-117A4	12.96	14.14	4.88	0.34	0.67	0.00	0.00	0.17
Synoviocyte, donor2	11368-117I9	14.92	14.42	7.04	1.17	0.50	0.17	0.67	0.34
Synoviocyte, donor3	11440-118H9	14.07	13.18	3.13	0.67	0.45	0.00	0.45	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	12.15	8.93	6.79	0.36	0.36	0.36	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	11.89	9.91	1.98	0.00	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	5.33	15.75	4.63	0.00	0.00	0.23	0.00	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	10.54	5.02	7.46	0.43	0.72	0.00	0.07	0.29
Tracheal Epithelial Cells, donor2	11369-118A1	6.96	4.64	7.73	0.00	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	4.58	4.01	1.15	0.00	0.00	0.00	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	27.80	36.54	6.52	0.62	2.21	0.00	0.12	0.74
Urethra, donor2	10319-105A4	17.98	84.53	3.60	1.80	1.80	1.80	1.80	0.00
Urothelial Cells, donor1	11520-119H8	14.61	6.11	7.44	0.00	0.53	0.00	0.00	0.80
Urothelial Cells, donor2	11600-120H7	19.23	9.61	11.22	0.40	1.60	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	16.50	9.63	9.17	0.00	0.92	0.00	0.00	0.23
Urothelial cells, donor0	11216-116B1	38.12	9.81	13.60	0.89	0.67	0.00	0.00	1.56
Whole blood (ribopure), donor090309, donation1	12179-129A1	16.91	1.78	1.78	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	14.30	0.00	2.86	1.43	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	6.16	3.42	3.42	0.68	0.00	0.00	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	13.08	2.75	6.89	0.69	0.00	0.00	0.34	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	14.53	2.32	4.07	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	5.21	3.12	3.12	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	14.68	0.92	3.67	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	7.30	0.91	5.48	0.00	0.00	0.00	1.83	0.00
Wilms' tumor cell line:G-401	10809-111A8	14.80	7.53	5.18	0.62	0.37	0.00	0.37	0.12
Wilms' tumor cell line:HFWT	10597-108E3	25.52	16.72	7.04	0.00	2.64	0.00	0.00	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	18.71	17.60	6.98	0.56	2.23	0.56	0.28	0.28
achilles tendon, donor2	10292-104G4	10.33	28.93	4.13	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	30.59	3.82	19.89	1.27	0.25	0.00	0.25	1.27
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	11.38	10.22	7.20	1.16	0.46	0.00	0.00	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	21.60	5.82	10.68	1.19	0.83	0.00	0.00	0.95
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	16.33	1.36	10.34	0.27	0.27	0.00	0.00	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	10.68	2.53	7.87	1.97	0.00	0.00	0.28	0.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	11.00	11.63	7.82	0.21	0.42	0.00	0.21	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	21.23	16.60	9.80	0.00	0.00	0.27	0.27	1.09
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	5.73	7.49	5.73	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	20.83	9.80	9.39	0.41	0.00	0.00	0.41	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	16.31	24.46	8.54	0.78	1.55	0.39	0.39	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	8.28	3.86	7.54	0.74	0.37	0.00	0.00	0.55
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	7.80	23.40	0.00	7.80	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	7.44	9.06	8.37	0.93	0.46	0.00	0.70	0.93
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	12.17	6.99	6.99	0.26	0.26	0.00	0.78	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	11.69	10.81	7.01	1.46	0.29	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	12.08	18.13	3.72	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	17.27	15.22	9.05	0.41	2.06	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	7.98	10.13	2.76	0.00	0.61	0.31	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	11.95	9.39	5.12	0.43	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	9.10	6.07	2.73	1.21	0.30	0.00	0.00	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	13.24	6.50	5.05	0.48	0.96	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	14.48	6.24	7.35	0.67	0.22	0.00	0.22	0.67
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	7.00	9.67	3.34	0.67	0.33	0.67	0.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	7.43	9.29	5.57	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	1.88	5.65	2.64	0.38	0.38	0.38	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	3.93	17.01	3.49	0.00	0.00	0.00	0.00	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	3.75	1.87	0.00	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	10.83	23.79	4.71	0.71	0.47	0.00	0.24	0.00
adipose tissue, adult, pool1	10010-101C1	33.97	22.49	10.08	2.02	1.09	0.62	0.16	0.78
adipose, donor1	10184-103D4	5.28	17.59	7.04	0.00	1.17	0.00	0.00	0.59
adipose, donor2	10185-103D5	4.87	24.74	3.24	2.43	0.81	0.81	0.00	1.22
adipose, donor3	10186-103D6	4.90	27.77	3.81	0.82	1.09	0.54	0.00	0.54
adipose, donor4	10187-103D7	10.40	10.40	3.47	0.00	0.87	0.87	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	1.26	7.26	2.37	0.00	0.47	0.32	0.00	1.26
adrenal gland, adult, pool1	10081-102A9	7.28	29.10	3.64	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	6.14	4.54	5.74	0.00	0.13	0.00	0.00	0.67
alveolar cell carcinoma cell line:SW 1573	10708-109H6	24.65	11.79	9.65	0.71	0.71	0.00	0.00	0.36
amniotic membrane cells, donor1	12235-129G3	38.49	50.31	11.36	0.93	4.64	0.00	0.70	0.23
amniotic membrane cells, donor2	12236-129G4	16.91	28.06	5.75	0.68	2.70	0.34	0.34	0.34
amniotic membrane cells, donor3	12237-129G5	50.08	50.67	9.43	0.88	6.19	0.59	1.18	0.29
amygdala - adult, donor10196	10167-103B5	20.16	17.79	7.11	0.00	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	27.58	25.14	5.27	2.64	1.42	0.00	1.42	0.41
amygdala, newborn, donor10223	10360-105E9	15.49	11.30	2.90	0.32	0.65	0.00	0.32	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	44.82	30.69	14.01	1.40	2.04	0.13	0.00	0.64
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	93.99	10.15	33.76	1.76	0.66	0.00	0.00	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	18.04	45.10	7.68	0.33	4.01	0.33	0.00	1.67
aorta, adult, pool1	10052-101G7	37.27	25.30	9.81	3.14	1.18	0.20	0.59	0.39
appendix, adult	10189-103D9	19.41	22.51	7.76	0.39	0.39	0.00	0.39	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	11.69	17.20	4.13	1.03	1.03	0.69	0.00	0.69
artery, adult	10190-103E1	13.59	16.30	4.08	0.00	1.36	0.00	4.08	1.36
astrocytoma cell line:TM-31	10425-106D2	14.78	22.16	8.98	0.58	0.87	0.14	0.29	0.14
b cell line:RPMI1788	10427-106D4	9.22	1.34	4.61	0.59	0.00	0.00	0.00	1.78
basal cell carcinoma cell line:TE 354.T	10702-109G9	19.42	8.05	4.44	1.39	0.00	0.00	0.00	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	14.19	9.43	5.26	0.69	1.29	0.00	0.00	0.69
bile duct carcinoma cell line:TFK-1	10496-107C1	6.36	3.85	1.84	0.00	0.33	0.00	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	4.47	11.74	2.24	0.00	0.56	0.00	0.00	0.56
bladder, adult, pool1	10011-101C2	32.38	24.44	9.45	2.06	0.98	0.43	0.33	0.22
blood, adult, pool1	10053-101G8	4.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	10.28	13.70	3.43	0.00	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	15.52	12.15	6.07	1.35	0.67	0.00	1.35	0.00
brain, adult, donor1	10084-102B3	19.48	15.38	2.05	2.05	1.03	0.00	0.00	2.05
brain, adult, pool1	10012-101C3	26.61	18.93	5.12	2.45	1.00	0.45	0.00	0.67
brain, fetal, pool1	10085-102B4	5.34	0.00	2.67	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	12.22	17.84	1.65	0.33	0.66	0.00	0.33	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	4.62	21.59	2.62	0.37	0.75	0.25	0.00	0.00
breast, adult, donor1	10080-102A8	39.78	29.67	10.10	1.89	2.53	0.00	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	9.27	2.79	3.18	0.51	0.00	0.00	0.13	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	11.44	7.11	7.73	0.93	0.00	0.00	0.00	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	6.68	8.98	8.06	0.00	0.46	0.00	0.46	2.30
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	13.31	17.19	4.36	0.97	0.73	0.00	0.00	0.73
carcinoid cell line:NCI-H1770	10703-109H1	12.69	5.64	8.93	0.47	0.47	0.00	0.47	0.47
carcinoid cell line:NCI-H727	10735-110B6	12.47	14.44	4.48	0.33	0.98	0.11	0.11	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	51.97	15.53	20.60	0.32	1.90	0.32	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	16.77	25.29	7.45	0.27	1.33	0.00	0.53	0.53
caudate nucleus - adult, donor10196	10177-103C6	29.93	23.03	3.45	0.00	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	24.76	23.09	6.69	1.34	1.00	0.17	0.00	0.67
caudate nucleus, adult, donor10258	10379-105H1	21.40	16.05	3.06	0.76	0.00	0.00	0.00	1.53
caudate nucleus, newborn, donor10223	10354-105E3	28.57	19.78	8.06	1.83	1.46	0.00	0.37	0.73
cerebellum - adult, donor10196	10173-103C2	40.79	11.65	8.74	2.91	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	29.68	32.67	8.33	2.35	1.92	0.43	0.21	0.64
cerebellum, adult, pool1	10083-102B2	20.35	9.66	7.24	2.76	0.00	0.00	0.34	0.00
cerebellum, newborn, donor10223	10357-105E6	32.38	34.04	11.62	0.83	0.00	0.00	0.00	0.83
cerebral meninges, adult	10188-103D8	18.41	18.66	4.29	0.76	1.01	0.00	0.00	0.50
cerebrospinal fluid, donor2	10294-104G6	15.35	13.16	2.92	0.73	0.00	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	9.63	1.87	4.74	1.01	0.00	0.00	0.00	0.29
cervical cancer cell line:ME-180	10553-107I4	39.77	8.62	10.61	0.17	1.66	0.00	0.00	0.17
cervix, adult, pool1	10013-101C4	22.15	50.71	7.87	1.15	2.10	0.63	0.31	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	78.03	19.93	20.34	1.67	0.98	0.14	0.14	0.56
chondrosarcoma cell line:SW 1353	10700-109G7	10.45	6.53	6.53	1.31	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	13.55	12.18	8.20	0.62	0.50	0.25	0.25	0.37
choriocarcinoma cell line:SCH	10785-110H2	7.39	8.38	3.08	0.37	0.00	0.00	0.00	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	9.49	5.69	6.40	0.00	1.19	0.00	0.00	0.24
chorionic membrane cells, donor1	12238-129G6	21.65	31.91	11.40	1.42	2.28	0.00	0.00	1.14
chorionic membrane cells, donor2	12239-129G7	18.49	9.45	8.75	0.60	0.20	0.30	0.00	0.40
chorionic membrane cells, donor3	12240-129G8	20.33	25.28	3.85	1.10	1.10	0.00	1.10	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	9.09	0.00	2.02	0.00	0.00	0.00	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	8.07	8.07	3.65	0.19	0.19	0.00	0.00	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	9.71	6.12	4.22	0.63	0.00	0.21	0.00	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	3.34	3.34	4.37	0.51	0.00	0.00	0.00	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	4.84	1.69	4.11	0.24	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	5.90	1.22	2.85	0.20	0.20	0.00	0.00	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	15.61	5.01	10.01	0.59	0.00	0.00	0.00	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	4.43	4.95	3.91	0.52	0.26	0.00	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	16.69	13.26	11.43	0.23	1.14	0.00	2.29	0.46
clear cell carcinoma cell line:TEN	10636-108I6	9.89	11.62	3.47	0.00	0.69	0.00	0.00	0.35
colon carcinoma cell line:CACO-2	10513-107D9	3.84	9.15	2.56	0.37	0.00	0.00	0.00	0.18
colon carcinoma cell line:COLO-320	10420-106C6	24.71	13.68	11.02	0.00	1.14	0.38	0.00	2.28
colon, adult, donor1	10082-102B1	11.90	23.80	5.95	0.00	0.00	0.00	0.00	2.38
colon, adult, pool1	10014-101C5	25.26	37.84	7.76	2.12	1.41	0.12	0.00	0.47
colon, fetal, donor1	10070-101I7	19.78	16.07	6.18	3.09	1.85	0.00	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	22.92	55.00	22.92	0.00	0.00	0.00	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	25.04	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	14.02	15.30	4.67	0.00	1.27	0.42	0.00	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	8.75	11.32	6.94	0.15	0.60	0.00	0.15	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	12.55	9.45	8.04	0.71	0.56	0.00	0.14	0.00
corpus callosum, adult, pool1	10042-101F6	56.39	49.97	10.17	6.63	1.77	0.55	0.22	0.88
cruciate ligament, donor2	10295-104G7	20.26	31.61	4.05	0.81	1.62	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	13.64	18.46	2.41	0.00	0.00	0.80	1.61	0.00
diencephalon, adult	10193-103E4	29.52	24.00	5.28	2.16	1.92	0.00	0.00	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	8.04	1.15	4.13	0.46	0.00	0.69	0.46	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	16.16	3.33	3.85	0.51	0.26	0.00	0.00	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	27.44	7.70	9.15	0.00	0.48	0.00	0.00	0.48
ductus deferens, adult	10196-103E7	10.47	37.38	6.48	1.00	1.99	0.50	1.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	12.96	18.72	2.88	0.00	5.76	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	9.56	29.43	2.94	0.74	0.74	0.00	0.00	0.00
dura mater, adult, donor1	10041-101F5	24.86	15.86	7.93	1.73	0.33	0.08	0.00	0.66
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	21.76	26.65	7.33	0.22	0.89	0.00	0.00	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	20.06	9.46	8.88	0.43	0.72	0.29	0.00	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	6.17	8.02	3.70	0.00	0.62	0.00	0.00	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	6.66	6.66	3.63	0.00	0.91	0.00	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	8.95	11.11	4.63	0.00	0.62	0.31	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	5.25	5.25	5.25	1.31	0.00	0.00	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	9.05	10.06	4.69	0.00	0.00	0.00	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	16.85	15.22	6.16	0.91	0.54	0.36	0.00	0.72
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	16.08	12.06	4.18	0.48	0.80	0.16	0.64	0.00
epidermoid carcinoma cell line:A431	10426-106D3	25.68	26.68	10.78	0.67	3.56	0.22	0.00	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	33.55	6.82	14.19	0.88	0.88	0.00	0.11	0.99
epididymis, adult	10197-103E8	32.65	49.40	9.21	0.84	2.09	0.00	0.21	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	30.51	11.18	12.42	1.06	0.71	0.18	0.35	1.24
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	10.62	3.54	8.26	0.00	0.00	0.39	0.00	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	28.70	12.45	17.43	0.66	0.39	0.00	1.31	1.05
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	31.20	19.29	15.26	0.69	0.39	0.00	1.18	0.89
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	31.59	12.21	13.67	1.57	0.45	0.11	1.23	0.45
esophagus, adult, pool1	10015-101C6	20.07	23.36	7.01	1.49	1.70	0.21	0.32	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	60.86	30.43	21.16	1.25	2.00	0.13	0.25	1.13
eye - muscle inferior rectus, donor1	10272-104E2	14.49	31.39	4.83	0.00	7.24	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	10.52	10.52	4.21	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	14.88	37.21	1.49	1.49	1.49	0.00	0.00	1.49
eye - muscle superior, donor2	10297-104G9	5.73	32.10	2.29	0.00	1.15	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	11.66	7.29	5.83	2.91	1.46	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	28.73	19.07	9.15	1.27	0.76	0.25	0.25	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	25.26	9.75	15.52	0.51	0.51	0.26	0.00	0.64
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	21.61	6.89	12.82	0.24	0.24	0.00	0.47	0.24
frontal lobe, adult, pool1	10040-101F4	23.74	16.51	4.79	3.19	0.75	0.09	0.00	0.84
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	5.10	12.31	1.50	0.00	0.30	0.00	0.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	12.89	10.52	10.33	0.55	0.55	0.09	0.00	0.64
gall bladder, adult	10198-103E9	16.90	28.97	5.07	1.45	0.24	0.48	0.24	0.72
gamma delta positive T cells, donor1	11937-126A2	15.03	0.00	4.29	1.07	0.00	0.00	0.00	0.54
gamma delta positive T cells, donor2	11938-126A3	15.31	2.24	3.73	0.37	0.00	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	26.82	17.11	9.93	0.21	1.69	0.21	1.69	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	11.22	9.86	3.87	0.97	1.16	0.00	0.19	0.19
gastric cancer cell line:AZ521	10549-107H9	13.12	13.28	5.08	0.98	1.64	0.16	0.33	0.82
gastric cancer cell line:GSS	10560-108A2	17.39	20.13	14.64	0.92	2.75	0.00	0.00	4.58
gastrointestinal carcinoma cell line:ECC12	10615-108G3	10.51	13.25	5.48	0.46	0.69	0.00	0.23	0.23
giant cell carcinoma cell line:LU65	10487-107B1	13.20	4.82	7.80	0.23	0.00	0.00	0.23	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	40.73	14.28	20.29	0.84	0.70	0.00	0.14	0.98
glassy cell carcinoma cell line:HOKUG	10688-109F4	8.98	12.72	3.99	0.00	0.50	0.25	0.25	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	11.93	9.39	3.69	0.84	0.11	0.32	0.00	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	7.02	8.71	3.09	0.70	0.14	0.14	0.00	0.42
glioblastoma cell line:T98G	10485-107A8	9.60	8.72	2.76	1.10	0.55	0.00	0.00	0.22
glioma cell line:GI-1	10413-106B8	26.65	14.64	5.56	1.46	1.17	0.00	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	38.63	29.16	4.37	8.75	2.92	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	67.61	54.43	10.98	6.59	1.22	0.49	0.73	0.49
globus pallidus, adult, donor10258	10367-105F7	30.12	41.08	1.37	1.37	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	33.04	30.91	6.40	1.07	1.07	0.00	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	26.92	46.50	17.13	0.00	2.45	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	10.93	0.00	10.93	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	15.68	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	14.40	12.80	4.48	0.32	0.32	0.00	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	8.26	6.43	1.84	0.46	0.92	0.00	0.46	0.46
hIPS +CCl2, biol_rep2	14384-156C1	5.94	10.06	1.37	1.37	0.00	0.00	0.46	0.46
hIPS +CCl2, biol_rep3	14385-156C2	7.73	12.88	0.64	0.64	0.64	0.00	0.00	0.64
hIPS, biol_rep1	14380-156B6	4.31	2.87	1.44	0.00	0.00	0.00	0.00	1.44
hIPS, biol_rep2	14381-156B7	9.60	8.92	1.37	0.00	0.00	1.37	0.69	0.00
hIPS, biol_rep3	14382-156B8	28.69	19.86	4.41	0.00	1.10	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	12.36	2.01	8.33	0.00	0.00	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	20.03	23.62	4.78	0.90	1.49	0.00	0.60	0.00
heart - pulmonic valve, adult	10206-103F8	14.90	22.23	3.66	1.31	0.00	0.26	0.52	0.26
heart - tricuspid valve, adult	10207-103F9	33.31	25.81	17.49	0.00	0.00	0.00	0.83	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	12.45	12.86	3.47	1.02	0.61	0.20	0.20	0.00
heart, adult, diseased, donor1	10051-101G6	19.59	12.77	4.26	0.43	0.43	0.00	1.28	0.43
heart, adult, pool1	10016-101C7	20.93	14.03	9.20	0.92	0.23	0.23	0.00	0.46
heart, fetal, pool1	10046-101G1	12.42	21.46	6.78	0.82	0.82	0.00	0.10	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	13.58	10.49	4.63	0.31	0.93	0.00	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	4.76	35.68	3.57	0.00	2.38	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	7.29	9.28	4.42	0.55	0.33	0.22	0.22	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	7.16	10.20	3.76	0.12	0.24	0.12	0.49	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	8.59	10.31	5.15	0.61	0.20	0.10	0.10	0.20
hepatoma cell line:Li-7	10484-107A7	7.23	14.90	3.78	0.11	0.44	0.11	0.00	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	8.64	5.53	7.84	0.40	0.80	0.10	0.00	1.41
hippocampus - adult, donor10196	10169-103B7	22.71	17.03	2.84	0.95	0.95	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	36.13	36.74	6.74	3.06	2.86	0.41	0.41	0.20
hippocampus, adult, donor10258	10374-105G5	17.93	11.45	1.49	1.00	0.50	0.50	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	17.27	14.10	5.64	1.06	0.35	0.35	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	4.88	11.60	12.82	1.22	0.61	0.00	1.83	2.44
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	5.89	8.05	7.46	0.20	0.20	0.20	0.39	1.57
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	6.60	12.69	9.39	0.76	0.76	0.25	0.25	3.05
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	1.13	16.35	4.51	0.56	1.13	0.00	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	6.46	19.11	3.10	0.00	2.32	0.26	0.52	1.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	8.35	18.60	7.59	1.14	0.00	0.00	0.00	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	6.13	32.70	5.55	1.46	0.29	1.46	0.00	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	9.05	28.22	5.39	0.65	1.08	0.43	0.22	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	5.42	32.53	3.34	0.83	2.92	0.00	0.00	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	7.10	23.21	3.79	0.24	0.71	0.71	0.47	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	5.63	26.04	2.89	0.64	0.96	0.80	0.32	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	9.43	21.55	3.37	0.67	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	6.73	8.92	6.73	0.78	0.16	0.16	0.16	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	5.40	11.30	7.37	1.47	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	6.11	3.49	5.24	0.00	0.00	0.00	0.00	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	8.59	15.85	5.15	0.57	0.76	0.76	0.00	1.53
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	7.41	14.39	4.80	0.87	0.00	0.44	0.00	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	7.00	23.49	4.50	0.00	2.00	1.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	9.04	11.30	2.83	0.75	0.94	0.38	0.19	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	9.09	13.19	3.18	1.36	1.36	0.00	0.91	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	7.83	21.61	6.58	0.31	0.31	0.31	0.00	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	8.00	17.96	4.57	1.47	1.31	0.33	0.16	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	6.10	15.68	2.61	0.00	1.74	0.58	0.00	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	9.27	27.20	2.99	0.90	2.39	1.20	0.60	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	8.87	11.27	7.76	0.37	0.37	0.37	0.18	1.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	11.41	13.98	5.14	0.00	1.43	0.29	0.29	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	14.29	16.33	8.98	0.00	1.22	0.00	0.82	3.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	8.10	12.67	3.52	0.00	0.00	0.35	0.35	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	6.65	13.62	4.12	0.00	1.90	0.63	0.00	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	8.17	18.16	3.63	0.61	1.21	0.61	0.00	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	12.41	20.68	2.59	0.00	0.52	1.55	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	7.97	15.28	3.32	0.66	0.66	0.66	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	6.41	19.75	3.59	0.51	0.26	0.26	0.00	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	6.39	18.66	2.81	0.26	0.77	0.00	0.51	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	8.33	16.66	2.27	1.51	0.76	0.00	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	11.09	16.80	3.70	0.67	0.34	0.34	0.34	1.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	7.97	12.08	8.21	0.48	0.48	0.24	0.00	0.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	12.92	10.25	10.25	0.45	0.45	0.45	1.78	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	9.27	15.61	7.32	0.98	0.00	0.00	0.49	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	7.95	17.11	3.36	0.61	0.31	0.00	0.31	0.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	39.04	16.27	16.27	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	6.62	14.23	3.64	0.33	0.33	0.99	0.33	0.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	6.02	26.82	3.83	0.00	1.64	2.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	6.88	23.88	2.90	0.72	0.36	1.09	0.00	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	7.12	20.64	3.56	0.71	0.00	0.71	0.00	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	7.16	22.67	1.19	0.00	1.19	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	7.31	23.70	3.79	0.54	2.30	0.14	0.00	0.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	8.35	20.74	2.69	0.81	0.81	0.54	0.00	0.00
immature langerhans cells, donor1	11904-125F5	44.55	11.14	15.74	0.48	2.66	0.48	0.48	0.48
immature langerhans cells, donor2	11905-125F6	64.95	25.35	14.26	3.17	1.58	0.00	1.58	0.79
insula, adult, pool1	10039-101F3	22.05	16.37	6.53	2.27	1.32	0.38	0.09	0.38
keratoacanthoma cell line:HKA-1	10791-110H8	25.36	14.96	11.38	0.65	0.33	0.00	0.00	0.98
kidney, adult, pool1	10017-101C8	19.73	25.33	7.71	1.50	1.10	0.00	0.30	0.70
kidney, fetal, pool1	10045-101F9	14.71	22.00	6.72	0.99	1.13	0.07	0.07	0.57
large cell lung carcinoma cell line:IA-LM	10509-107D5	40.48	21.16	20.31	0.43	1.70	0.00	0.00	0.57
large cell lung carcinoma cell line:NCI-H460	10839-111E2	15.21	18.11	6.64	0.28	0.55	0.00	0.14	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	18.72	6.42	5.87	0.37	0.73	0.00	0.00	0.18
left atrium, adult, donor1	10079-102A7	20.16	16.35	5.99	1.09	0.54	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	16.18	11.63	5.56	1.01	0.51	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	0.55	7.66	2.46	0.00	0.27	0.27	0.00	0.55
leiomyoma cell line:10964C	10569-108B2	21.20	7.54	7.18	1.08	0.36	0.00	0.36	0.00
leiomyoma cell line:15242A	10570-108B3	23.37	4.35	3.80	0.00	0.00	0.00	0.54	0.54
leiomyoma cell line:15425	10571-108B4	24.77	7.53	7.53	0.24	0.24	0.00	0.97	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	6.35	6.35	6.35	0.00	0.00	0.00	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	20.91	19.87	4.18	0.00	0.00	0.00	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	13.22	11.92	10.03	0.35	0.71	0.12	0.00	0.35
liposarcoma cell line:KMLS-1	10782-110G8	16.56	12.50	7.50	0.47	0.31	0.31	0.47	0.16
liposarcoma cell line:SW 872	10726-110A6	12.79	15.60	4.63	0.24	0.61	0.12	0.12	0.00
liver, adult, pool1	10018-101C9	83.14	38.41	25.77	1.62	1.46	0.32	0.00	0.32
liver, fetal, pool1	10086-102B5	15.05	15.05	4.70	0.94	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	37.62	30.48	5.98	4.37	1.90	0.15	0.44	0.44
locus coeruleus, adult, donor10252	10165-103B3	47.80	32.85	8.67	3.69	1.85	0.37	1.48	0.55
locus coeruleus, adult, donor10258	10375-105G6	38.09	36.68	5.92	1.13	1.13	0.00	1.41	1.13
locus coeruleus, newborn, donor10223	10362-105F2	24.82	26.08	8.41	2.10	0.84	0.00	0.42	0.00
lung adenocarcinoma cell line:A549	10499-107C4	7.89	11.76	2.35	0.00	0.42	0.28	0.14	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	4.83	13.10	3.45	0.00	2.07	0.00	0.00	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	11.07	11.20	8.44	0.66	0.26	0.13	0.26	0.53
lung, adult, pool1	10019-101D1	22.44	17.72	8.62	1.77	1.42	0.24	0.00	0.47
lung, fetal, donor1	10068-101I5	17.98	31.11	4.57	0.29	1.43	0.29	0.00	0.86
lung, right lower lobe, adult, donor1	10075-102A3	21.54	32.08	5.50	3.21	0.92	0.00	0.00	0.00
lymph node, adult, donor1	10077-102A5	15.62	8.99	7.10	1.89	0.95	0.00	0.00	0.47
lymphangiectasia cell line:DS-1	10727-110A7	8.33	5.48	8.33	0.66	0.00	0.00	0.22	0.88
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	19.02	4.98	17.96	1.36	0.00	0.00	0.30	1.51
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	15.29	6.80	5.95	0.00	0.85	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	41.74	32.41	10.66	4.44	1.78	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	39.43	22.83	4.77	3.32	2.08	0.62	0.00	0.21
mature adipocyte, donor3	12233-129G1	37.46	20.39	8.06	2.37	0.95	0.47	0.24	0.47
mature adipocyte, donor4	12234-129G2	35.80	27.11	7.11	2.11	1.32	0.26	0.26	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	10.48	28.35	2.86	0.24	1.19	0.00	0.00	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	13.54	16.92	2.26	0.00	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	32.92	24.09	6.25	1.66	0.92	0.18	1.10	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	17.47	14.30	3.81	1.91	0.64	0.00	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	15.78	6.40	5.54	0.00	0.00	0.00	0.43	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	21.43	18.06	6.58	2.53	0.68	0.00	1.18	0.68
medial temporal gyrus, adult, donor10252	10156-103A3	29.07	34.17	6.37	2.33	2.33	0.21	0.21	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	17.34	7.71	3.85	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	14.35	14.35	0.00	0.00	0.00	14.35	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	13.64	8.26	5.74	0.36	0.72	0.00	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	28.56	29.85	7.79	1.30	1.95	0.65	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	47.83	39.47	8.20	3.25	1.70	0.31	0.93	0.62
medulla oblongata, adult, pool1	10038-101F2	43.75	27.10	8.90	5.22	1.47	0.49	0.33	0.57
medulla oblongata, newborn, donor10223	10361-105F1	28.82	33.33	7.99	1.74	1.04	0.69	0.69	0.35
medulloblastoma cell line:D283 Med	10838-111E1	17.49	26.35	11.73	0.44	2.21	0.66	0.22	1.33
medulloblastoma cell line:ONS-76	10759-110E3	20.18	9.29	7.70	0.86	0.12	0.00	0.00	0.37
melanoma cell line:COLO 679	10514-107E1	12.65	22.57	5.61	0.29	1.15	0.29	0.00	0.14
melanoma cell line:G-361	10465-106H6	23.07	19.27	6.24	1.90	0.81	0.00	0.54	0.54
meningioma cell line:HKBMM	10691-109F7	24.42	13.21	7.42	0.36	1.27	0.00	0.72	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	21.15	18.50	5.29	1.76	0.88	0.88	0.88	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	14.00	15.81	9.07	1.04	0.26	0.00	0.52	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	16.11	8.75	6.60	0.77	0.61	0.00	0.46	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	17.45	7.63	5.64	0.18	0.55	0.00	0.18	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	7.04	7.45	2.90	0.41	0.83	0.00	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	33.43	5.90	5.62	0.84	0.14	0.14	0.14	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	30.23	8.28	6.16	0.77	0.39	0.00	0.00	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	25.68	11.80	8.33	0.69	0.00	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	42.22	6.52	10.64	1.37	0.86	0.00	0.86	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	24.84	8.51	7.13	0.46	0.58	0.00	0.23	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	19.50	6.90	7.56	0.40	0.40	0.00	0.40	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	27.14	8.24	8.37	0.81	0.27	0.14	0.27	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	33.57	6.69	11.38	1.00	0.28	0.14	0.85	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	33.26	18.77	11.53	1.32	0.66	0.00	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	17.43	8.86	6.64	0.42	0.28	0.00	0.28	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	19.90	5.24	7.33	0.70	0.00	0.35	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	28.99	5.92	6.33	1.22	0.20	0.00	0.41	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	21.57	5.75	5.75	0.00	0.36	0.36	0.00	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	17.79	5.07	6.52	0.52	0.00	0.00	0.21	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	18.24	5.02	5.47	0.46	1.14	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	27.69	4.20	6.71	1.26	0.00	0.42	1.26	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	21.22	6.43	8.37	0.45	0.30	0.00	0.60	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	24.68	7.79	7.97	0.35	1.05	0.09	0.26	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	54.12	8.84	12.15	1.84	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	16.88	7.44	7.44	0.86	0.00	0.29	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	10.10	7.58	7.16	0.84	0.42	0.00	0.00	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	9.59	6.39	2.28	0.91	0.91	0.00	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	9.98	8.19	3.84	0.26	0.00	0.00	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	15.18	10.73	2.88	0.26	0.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	12.32	8.01	4.31	0.62	0.31	0.00	0.62	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	11.06	11.06	2.59	0.47	0.24	0.00	0.47	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	11.51	10.83	3.05	1.35	0.00	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	11.00	6.29	6.68	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	8.80	9.27	3.71	0.00	0.46	0.00	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	13.84	10.09	5.77	0.00	1.15	0.00	0.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	12.72	8.03	3.79	0.22	0.67	0.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	12.98	9.85	4.81	0.00	0.00	0.24	0.24	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	19.80	15.40	3.67	0.73	1.47	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	11.08	10.07	4.70	0.00	0.34	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	12.28	6.96	5.73	0.00	0.41	0.00	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	9.45	12.03	6.01	0.86	0.00	0.00	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	21.88	8.20	2.73	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	5.16	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	9.74	8.12	3.25	0.00	0.65	0.32	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	14.55	4.36	4.36	0.00	0.00	0.00	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	17.59	13.86	4.80	0.00	0.00	0.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	12.27	9.00	8.18	1.64	1.64	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	12.05	7.39	5.05	0.00	0.78	0.00	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	16.79	12.59	14.69	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	10.93	2.98	5.96	0.00	0.99	0.99	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	9.53	4.77	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	14.82	9.49	2.96	0.00	1.19	0.59	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	15.84	6.09	7.31	0.00	0.00	0.00	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	27.05	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	10.13	7.60	7.60	0.00	0.00	0.63	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	10.35	12.07	3.10	0.34	0.00	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	4.30	2.15	4.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	11.98	3.99	0.00	0.00	0.00	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	0.00	24.11	0.00	0.00	0.00	0.00	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	6.93	12.63	0.81	0.00	0.41	0.00	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	5.56	15.89	2.38	1.59	0.00	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	8.84	12.38	0.59	1.18	0.00	0.00	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	9.66	10.60	3.74	0.31	0.62	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	8.02	17.38	5.35	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	11.83	2.37	0.00	1.18	0.00	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	12.84	17.98	2.57	2.57	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	9.64	16.52	2.07	0.00	0.00	0.00	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	4.45	14.84	1.48	0.00	0.49	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	6.73	13.46	1.12	1.12	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	2.54	17.81	0.64	0.00	0.64	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	7.25	12.90	3.22	0.81	0.40	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	10.90	13.08	2.18	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	6.34	16.47	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	18.21	18.21	3.64	1.21	0.00	0.00	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	27.11	22.59	13.56	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	26.36	27.18	4.94	0.00	1.65	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	20.24	10.91	3.57	0.60	0.60	0.40	0.20	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	17.20	12.98	4.87	0.32	0.65	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	14.26	8.15	4.07	0.00	2.04	0.00	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	16.25	30.95	13.15	0.00	1.55	0.77	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	21.97	9.69	9.21	0.94	0.24	0.24	0.00	0.94
mesothelioma cell line:ACC-MESO-4	10494-107B8	9.04	10.89	2.55	0.23	0.00	0.00	0.00	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	21.37	8.55	8.55	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	11.61	3.80	3.80	0.10	0.31	0.10	0.31	0.10
mesothelioma cell line:Mero-25	10850-111F4	13.39	12.03	6.58	0.45	0.68	0.00	0.00	0.23
mesothelioma cell line:Mero-41	10851-111F5	17.11	7.82	4.40	0.00	0.00	0.00	0.00	0.24
mesothelioma cell line:Mero-48a	10852-111F6	10.85	3.99	2.88	1.11	0.66	0.00	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	32.59	19.18	8.67	0.79	0.00	0.26	0.26	0.26
mesothelioma cell line:Mero-83	10854-111F8	15.49	6.13	5.45	0.34	0.34	0.00	0.17	0.17
mesothelioma cell line:Mero-84	10855-111F9	4.55	5.06	2.27	0.00	0.51	0.00	0.25	0.00
mesothelioma cell line:Mero-95	10856-111G1	22.98	11.18	7.04	1.86	1.24	0.21	0.41	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	25.84	9.11	8.94	0.17	0.66	0.17	0.17	0.17
mesothelioma cell line:NCI-H226	10846-111E9	11.40	4.71	3.98	0.36	0.18	0.00	0.00	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	13.32	9.91	3.93	0.68	0.00	0.34	0.00	0.51
mesothelioma cell line:NCI-H28	10845-111E8	3.82	2.54	3.05	0.25	0.00	0.00	0.25	0.00
mesothelioma cell line:No36	10857-111G2	15.33	10.76	3.59	0.65	0.33	0.00	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	16.53	4.06	1.90	0.00	0.27	0.00	0.00	0.27
migratory langerhans cells, donor1	11901-125F2	7.10	3.07	3.07	0.19	0.00	0.00	0.19	0.19
migratory langerhans cells, donor2	11902-125F3	7.69	1.59	2.56	0.85	0.24	0.00	0.00	0.24
migratory langerhans cells, donor3	11903-125F4	12.74	2.69	2.15	0.36	0.00	0.00	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	15.02	9.79	6.20	0.65	0.33	0.00	1.31	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	5.93	5.30	3.81	0.42	0.85	0.00	0.21	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	11.98	9.91	4.38	0.46	0.23	0.23	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	10.09	8.37	4.38	0.19	0.57	0.00	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	24.95	10.53	12.20	0.92	0.37	0.00	0.00	0.74
myeloma cell line:PCM6	10474-106I6	15.22	0.79	9.49	0.59	0.20	0.00	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	6.59	11.16	3.04	0.00	1.01	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	45.11	21.58	15.69	0.39	0.20	0.00	0.20	0.98
nasal epithelial cells, donor1, tech_rep1	12226-129F3	14.15	7.47	5.79	0.67	0.33	0.11	0.00	0.45
nasal epithelial cells, donor1, tech_rep2	12226-129F3	15.52	8.90	6.10	0.44	0.37	0.15	0.15	0.29
nasal epithelial cells, donor2	12227-129F4	15.46	6.62	4.97	0.55	0.00	0.55	0.00	1.10
neuroblastoma cell line:CHP-134	10508-107D4	12.65	21.63	6.90	0.46	0.69	0.00	0.00	1.84
neuroblastoma cell line:NB-1	10539-107G8	3.37	4.86	3.37	0.37	0.00	0.00	0.00	0.56
neuroblastoma cell line:NBsusSR	10607-108F4	94.90	75.71	26.57	0.84	5.69	1.90	1.05	0.42
neuroblastoma cell line:NH-12	10555-107I6	13.60	20.50	6.89	0.19	0.75	0.19	0.37	1.12
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	181.48	55.04	39.85	0.71	6.64	1.19	2.85	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	529.47	170.73	141.59	1.90	25.34	3.80	8.71	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	64.81	27.37	20.73	0.40	2.01	1.21	0.40	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	143.68	124.61	48.95	0.00	27.34	1.91	1.27	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	10.65	5.86	3.46	1.06	0.53	0.00	0.00	0.00
neutrophil PMN, donor1	12133-128D9	14.87	14.87	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	29.77	4.40	13.70	2.20	0.34	0.00	0.00	0.68
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	7.20	7.20	8.01	3.20	0.00	0.80	0.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	8.34	14.43	2.89	0.64	0.00	0.00	0.32	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	13.40	11.04	4.20	0.79	0.00	0.26	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	28.12	17.62	5.44	3.28	1.22	0.28	0.00	0.47
occipital cortex - adult, donor10196	10172-103C1	20.60	20.60	8.24	2.06	0.00	0.00	0.00	2.06
occipital cortex, adult, donor10252	10163-103B1	46.43	35.96	6.17	3.76	2.15	0.00	0.27	0.00
occipital cortex, newborn, donor10223	10355-105E4	15.29	6.19	5.82	0.36	0.36	0.36	0.00	0.36
occipital lobe, adult, donor1	10076-102A4	24.67	22.30	6.82	4.46	1.31	0.52	0.26	0.26
occipital lobe, fetal, donor1	10073-102A1	7.72	14.59	6.44	1.29	0.43	0.00	0.00	0.43
occipital pole, adult, pool1	10036-101E9	18.69	13.56	4.65	2.44	0.87	0.16	0.00	0.71
olfactory region, adult	10195-103E6	29.80	20.25	4.97	1.72	0.76	0.00	0.57	0.57
optic nerve, donor1	10277-104E7	64.03	78.04	8.00	0.00	4.00	0.00	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	13.44	26.31	4.78	0.91	0.80	0.11	0.11	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	10.03	6.87	6.46	0.82	0.41	0.00	0.00	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	12.36	6.94	4.91	0.51	0.34	0.00	0.68	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	22.18	11.90	7.85	0.23	0.12	0.23	0.00	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	16.17	16.76	7.64	0.00	0.88	0.29	0.00	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	33.64	21.49	23.36	0.00	0.93	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	8.06	2.97	0.42	0.42	0.00	0.00	0.00	0.21
ovary, adult, pool1	10020-101D2	25.51	31.80	6.90	1.22	1.66	0.44	0.09	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	9.17	8.98	6.60	0.55	0.18	0.00	0.00	0.37
pancreas, adult, donor1	10049-101G4	11.29	15.05	12.23	0.00	0.94	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	12.02	30.19	5.59	0.56	0.84	0.28	0.56	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	47.02	12.10	13.46	1.19	1.02	0.00	0.51	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	25.00	12.09	8.61	0.83	0.83	0.00	0.00	0.33
paracentral gyrus, adult, pool1	10035-101E8	26.45	16.57	7.23	2.20	0.73	0.27	0.37	0.46
parietal cortex, adult, donor10258	10373-105G4	23.49	14.68	0.73	0.00	0.00	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	15.05	12.23	1.88	0.94	0.94	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	29.36	21.38	6.56	2.57	0.29	0.00	1.14	0.00
parietal lobe, adult, pool1	10034-101E7	30.05	16.21	7.23	3.17	1.23	0.00	0.18	0.62
parietal lobe, fetal, donor1	10072-101I9	12.61	13.58	2.91	0.00	0.00	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	12.71	9.72	5.61	0.37	0.00	0.00	0.00	0.37
parotid gland, adult	10199-103F1	9.87	33.30	4.32	0.62	0.00	0.00	0.62	0.62
penis, adult	10200-103F2	14.50	29.00	5.37	1.61	0.54	0.54	3.22	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	183.52	33.10	28.08	0.93	5.39	0.56	0.93	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	14.57	13.55	4.81	0.87	0.44	0.29	0.00	0.15
pineal gland - adult, donor10196	10179-103C8	11.61	26.45	5.81	1.29	0.65	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	18.36	30.20	5.92	1.78	2.37	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	11.29	27.59	3.76	1.25	1.25	0.63	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	14.17	24.28	9.11	0.00	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	27.10	32.31	18.76	2.08	2.08	0.52	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	9.36	19.58	2.55	0.00	1.70	0.85	0.00	0.85
placenta, adult, pool1	10021-101D3	12.58	63.75	6.24	0.11	3.23	0.43	0.11	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	7.42	1.99	5.30	0.26	0.00	0.00	0.00	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	16.03	7.78	3.74	0.78	1.09	0.16	0.16	0.16
pons, adult, pool1	10033-101E6	31.33	20.23	7.57	3.87	0.77	0.43	0.17	0.43
postcentral gyrus, adult, pool1	10032-101E5	21.71	14.04	5.32	1.92	1.05	0.35	0.09	0.61
promyelocytes/myelocytes PMC, donor1	12132-128D8	6.27	29.28	8.37	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	22.03	11.02	0.00	0.00	0.00	0.00	0.00	5.51
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	11.74	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	15.15	4.66	7.28	1.02	0.15	0.00	0.00	0.15
prostate cancer cell line:PC-3	10439-106E7	17.42	19.78	6.53	0.18	1.63	0.18	0.00	0.18
prostate, adult, pool1	10022-101D4	19.77	39.45	7.80	1.36	1.27	0.36	0.09	0.45
putamen, adult, donor10196	10176-103C5	26.20	19.83	6.85	1.65	0.00	0.24	0.24	0.00
putamen, adult, donor10252	10152-102I8	31.37	35.29	5.88	1.96	1.96	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	14.21	12.02	3.28	0.00	1.09	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	25.85	21.02	4.59	1.69	0.24	0.24	0.00	0.48
putamen, newborn, donor10223	10365-105F5	20.99	17.99	4.50	0.00	0.75	0.00	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	10.47	19.20	4.95	0.58	1.45	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	9.74	34.77	6.95	0.00	1.39	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	12.08	9.96	3.82	0.64	0.21	0.00	0.21	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	36.45	17.40	12.84	0.41	0.00	0.41	0.00	0.00
retina, adult, pool1	10030-101E3	31.31	34.09	6.66	3.38	1.39	0.60	0.10	0.40
retinoblastoma cell line:Y79	10475-106I7	24.94	14.29	15.59	1.30	0.78	0.78	0.00	1.56
rhabdomyosarcoma cell line:KYM-1	10787-110H4	6.76	8.61	4.55	0.49	0.61	0.00	0.00	0.49
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	2.81	16.87	2.53	0.00	1.12	0.00	0.00	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	14.40	20.46	5.30	0.00	1.52	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	47.26	22.01	15.05	0.65	2.27	0.16	0.16	0.49
salivary acinar cells, donor2	11772-123I8	40.34	42.41	18.04	1.10	0.69	0.28	1.51	0.41
salivary acinar cells, donor3	11773-123I9	36.41	70.84	15.23	2.65	1.32	0.00	0.00	0.66
salivary gland, adult, pool1	10093-102C3	12.01	13.15	2.86	0.57	0.57	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	38.95	11.38	12.98	2.36	0.51	0.25	0.17	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	36.21	10.34	13.05	2.23	0.59	0.35	0.00	0.24
seminal vesicle, adult	10201-103F3	16.93	35.98	6.88	0.53	2.12	0.00	1.06	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	6.32	16.52	1.94	0.00	0.24	0.73	0.24	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	22.90	14.34	5.54	0.75	0.25	0.00	0.25	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	16.06	10.04	8.03	0.00	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	8.06	11.42	2.82	0.13	1.07	0.13	0.13	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	15.69	11.49	6.85	0.66	0.77	0.22	0.11	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	8.90	10.45	4.13	0.39	0.26	0.00	0.00	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	7.09	9.22	2.84	0.00	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	23.75	12.71	8.52	1.20	0.24	0.12	0.12	0.48
skeletal muscle, fetal, donor1	10066-101I3	6.03	14.07	0.00	0.00	1.01	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	33.93	40.71	0.00	0.00	6.79	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	17.67	29.67	6.94	1.26	2.52	0.00	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	16.34	5.67	6.00	1.00	1.00	0.00	0.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	13.55	26.79	10.09	0.63	1.58	0.63	0.63	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	9.64	7.52	5.98	0.19	0.96	0.19	0.19	1.93
small cell lung carcinoma cell line:LK-2	10541-107H1	10.22	8.57	5.44	0.49	0.49	0.00	0.00	1.15
small cell lung carcinoma cell line:NCI-H82	10842-111E5	12.06	7.56	7.56	0.16	0.32	0.00	0.32	2.25
small cell lung carcinoma cell line:WA-hT	10562-108A4	47.07	74.31	14.82	0.87	1.96	0.65	0.00	0.44
small intestine, adult, pool1	10024-101D6	25.56	23.89	8.96	1.79	1.19	0.12	0.12	0.12
small intestine, fetal, donor1	10064-101I1	7.37	12.78	3.69	0.74	0.25	0.00	0.00	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	16.41	12.31	3.59	1.03	0.51	0.00	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	20.93	25.59	6.72	3.36	1.03	0.00	0.52	0.00
somatostatinoma cell line:QGP-1	10781-110G7	6.70	6.70	2.68	0.54	0.54	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	50.01	37.16	8.95	3.90	2.52	0.46	1.38	0.69
spinal cord, adult, donor10252	10159-103A6	55.20	35.09	9.86	5.91	1.97	0.39	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	39.43	28.36	4.15	1.38	2.77	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	18.30	33.54	5.49	1.22	0.00	0.00	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	40.41	39.95	11.48	1.38	4.13	0.46	0.46	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	12.84	8.36	5.53	0.75	1.05	0.45	0.15	0.00
spleen, adult, pool1	10025-101D7	11.34	9.69	7.38	0.88	0.22	0.11	0.00	0.11
spleen, fetal, pool1	10044-101F8	10.17	14.70	4.45	0.48	0.32	0.16	0.00	0.40
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	5.69	3.21	3.73	0.10	0.10	0.00	0.00	0.41
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	8.16	7.78	1.90	0.00	0.19	0.00	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	12.58	17.47	2.80	0.35	1.75	0.00	0.00	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	28.54	11.34	8.60	0.00	0.78	0.00	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	32.19	18.01	12.61	0.79	1.80	0.11	0.00	0.56
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	13.98	8.47	3.39	0.00	0.42	0.00	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	5.50	4.23	4.65	0.85	0.00	0.42	0.00	0.00
stomach, fetal, donor1	10062-101H8	18.16	25.63	5.34	0.00	0.00	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	10.25	22.22	2.85	1.14	0.00	0.57	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	54.27	54.27	0.00	54.27	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	73.94	56.29	9.97	5.40	3.74	0.21	1.25	0.62
substantia nigra, adult, donor10258	10371-105G2	34.66	27.41	0.00	1.03	0.00	0.52	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	35.33	47.34	7.77	2.83	0.71	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	28.20	21.32	10.55	1.38	0.92	0.00	0.23	0.92
temporal lobe, adult, pool1	10031-101E4	25.18	14.83	4.58	2.12	1.19	0.08	0.00	0.76
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	12.82	7.12	4.99	2.85	0.71	0.71	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	10.55	9.23	3.08	0.00	0.00	0.00	0.44	0.00
tenocyte, donor1	11763-123H8	14.66	11.87	7.33	0.70	0.35	0.00	0.35	0.70
tenocyte, donor2	11765-123I1	22.89	19.84	11.83	0.38	0.76	0.00	0.76	0.38
tenocyte, donor3	11768-123I4	13.34	10.01	3.71	0.74	0.74	0.37	0.37	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	3.91	5.61	3.57	0.34	0.17	0.17	0.00	0.68
teratocarcinoma cell line:NCR-G1	10798-110I6	6.63	12.49	4.01	0.46	0.31	0.62	0.00	0.31
teratocarcinoma cell line:PA-1	10807-111A6	6.51	7.28	5.58	0.77	0.77	0.15	0.15	2.01
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	21.45	15.49	12.06	1.02	1.27	0.25	0.00	0.89
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	8.32	17.40	6.81	0.00	0.76	0.00	0.38	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	11.12	2.73	2.62	0.00	0.11	0.00	0.11	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	9.45	5.86	9.12	0.33	0.00	0.00	0.65	0.98
testis, adult, pool1	10026-101D8	20.62	37.58	6.55	0.43	1.07	0.43	0.21	0.32
testis, adult, pool2	10096-102C6	16.24	21.65	2.26	0.45	0.90	0.00	0.90	0.45
thalamus - adult, donor10196	10168-103B6	36.43	35.33	3.31	1.10	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	56.57	46.88	7.66	2.66	2.50	0.16	0.63	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	38.49	15.40	4.62	3.08	1.54	0.00	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	25.03	31.95	4.78	1.65	0.82	0.16	0.49	0.33
thalamus, newborn, donor10223	10366-105F6	12.66	9.78	5.18	0.00	0.58	0.00	0.58	0.00
throat, adult	10209-103G2	10.99	24.72	6.74	1.25	1.00	0.25	0.50	0.25
throat, fetal, donor1	10061-101H7	13.10	27.42	4.27	0.91	1.22	0.30	0.30	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	13.12	11.53	7.95	0.40	0.99	0.00	0.20	0.60
thymus, adult, pool1	10027-101D9	14.51	9.84	11.53	0.30	0.40	0.10	0.30	0.80
thymus, fetal, pool1	10043-101F7	17.98	9.14	8.42	1.04	0.52	0.00	0.10	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	19.81	8.24	7.71	0.40	0.13	0.13	0.27	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	27.94	9.22	10.90	0.70	0.42	0.00	0.14	0.28
thyroid, adult, pool1	10028-101E1	28.65	45.44	12.60	1.12	1.87	0.56	0.00	0.75
thyroid, fetal, donor1	10060-101H6	10.81	29.79	4.75	0.79	1.32	0.26	0.26	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	24.64	49.27	6.16	3.08	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	16.28	18.14	4.88	1.63	0.47	0.23	1.16	0.47
tongue, fetal, donor1	10059-101H5	7.88	20.49	3.94	0.39	0.39	0.39	0.39	0.39
tonsil, adult, pool1	10047-101G2	20.64	15.03	9.92	0.60	0.90	0.10	0.10	0.30
trachea, adult, pool1	10029-101E2	25.68	24.87	10.31	0.57	0.98	0.16	0.25	0.33
trachea, fetal, donor1	10058-101H4	16.93	28.47	8.85	0.38	1.15	0.00	0.77	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	12.40	9.92	4.61	0.35	0.35	0.35	0.00	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	9.12	16.62	6.18	0.61	1.42	0.00	0.00	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	15.36	11.59	13.79	0.63	0.16	0.00	0.47	0.78
tridermal teratoma cell line:HGRT	10694-109G1	11.42	26.64	3.81	1.90	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	10.50	13.37	4.49	0.51	0.08	0.08	0.17	0.42
umbilical cord, fetal, donor1	10057-101H3	16.69	10.43	4.17	2.09	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	26.45	32.25	4.10	1.19	2.56	0.00	0.34	0.68
uterus, fetal, donor1	10055-101H1	11.77	19.97	5.12	0.51	0.51	0.00	0.51	1.02
vagina, adult	10204-103F6	23.26	41.36	9.69	1.29	0.00	0.00	1.29	0.00
vein, adult	10191-103E2	16.66	14.91	5.04	0.88	0.88	0.00	0.00	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	6.94	2.67	3.20	0.00	0.00	0.00	0.00	0.53